MCID: RNV001
MIFTS: 48

Renovascular Hypertension

Categories: Cardiovascular diseases

Aliases & Classifications for Renovascular Hypertension

MalaCards integrated aliases for Renovascular Hypertension:

Name: Renovascular Hypertension 12 6 15 17 32
Hypertension, Renovascular 43 71
Hypertension Renovascular 54

Classifications:



External Ids:

Disease Ontology 12 DOID:1591
MeSH 43 D006978
NCIt 49 C85044
SNOMED-CT 67 123799005
ICD10 32 I15.0
UMLS 71 C0020545

Summaries for Renovascular Hypertension

MalaCards based summary : Renovascular Hypertension, also known as hypertension, renovascular, is related to malignant renovascular hypertension and fibromuscular dysplasia. An important gene associated with Renovascular Hypertension is REN (Renin), and among its related pathways/superpathways are cGMP-PKG signaling pathway and Insulin receptor recycling. The drugs Hydroxymethylglutaryl-CoA Reductase Inhibitors and Aspirin have been mentioned in the context of this disorder. Affiliated tissues include kidney, testes and heart, and related phenotypes are cardiovascular system and hematopoietic system

Wikipedia : 74 Renovascular hypertension is a condition in which high blood pressure is caused by the kidneys' hormonal... more...

Related Diseases for Renovascular Hypertension

Diseases in the Renovascular Hypertension family:

Benign Renovascular Hypertension Malignant Renovascular Hypertension

Diseases related to Renovascular Hypertension via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 355, show less)
# Related Disease Score Top Affiliating Genes
1 malignant renovascular hypertension 34.1 REN EDN1 AGTR1
2 fibromuscular dysplasia 31.3 YY1AP1 REN AGTR1 ACE
3 renal artery obstruction 31.2 REN ACE
4 arteriosclerosis 31.1 NOS3 HMOX1 EDN1 ACE
5 renal hypertension 31.0 REN NPPB NOS3 EDN1 AGTR1 ADM
6 acute kidney failure 31.0 REN NPPA LCN2 CAT
7 hypertension, diastolic 30.7 REN ACE
8 carotid stenosis 30.7 REN NOS3 ACE
9 renal artery disease 30.6 REN NPPA NOS3 AGTR1 ACE
10 multicystic dysplastic kidney 30.6 REN PKD1
11 hypertensive retinopathy 30.6 REN AGTR1 ACE
12 eclampsia 30.5 REN NOS3 EDN1 ACE
13 retinal vascular disease 30.4 REN NOS3 EDN1 ACE
14 hypertensive encephalopathy 30.4 REN NOS3 AGTR1 ACE
15 generalized atherosclerosis 30.3 REN ACE
16 sleep disorder 30.3 REN EDN1 ACE
17 limb ischemia 30.3 NOS3 EDN1 ACE
18 end stage renal disease 30.2 REN PKD1 NOS3 AGTR1 ACE
19 aortic valve insufficiency 30.2 REN NPPB ACE
20 microvascular complications of diabetes 3 30.2 REN AGTR1 ACE
21 atrial standstill 1 30.1 NPPB NPPA ACE
22 cerebral arterial disease 30.1 PKD1 NOS3 NF1 EDN1
23 ischemic colitis 30.1 JAK2 HMOX1 ACE
24 atherosclerosis susceptibility 30.1 NOS3 HMOX1 EDN1 AGTR1 ACE
25 sexual disorder 30.0 NOS3 NOS1 EDN1 ACE
26 congenital hepatic fibrosis 30.0 PKD1 AGTR1
27 cerebrovascular disease 30.0 REN NPPB NPPA AGTR1 ACE
28 patent ductus arteriosus 1 30.0 REN NPPB EDN1 ACE
29 angina pectoris 29.9 NPPB NOS3 EDN1 ACE
30 acute kidney tubular necrosis 29.9 REN NPPA LCN2 HMOX1 ACE
31 arteries, anomalies of 29.8 REN NOS3 EDN1 AGTR1 ACE
32 vascular dementia 29.8 SOD1 CAT ACE
33 peripheral nervous system disease 29.7 SOD1 REN NOS3 CAT ACE
34 peripheral artery disease 29.7 NPPB NOS3 HMOX1 EDN1 ACE
35 urinary tract obstruction 29.7 REN LCN2 AGTR1 ACE
36 cardiac arrest 29.6 REN NPPB LCN2 HMOX1 ACE
37 conn's syndrome 29.6 REN NPPA AGTR1 ACE
38 pheochromocytoma 29.6 REN NPPA NF1 EDN1 CAT ADM
39 cardiogenic shock 29.6 NPPB ADM
40 hypertensive heart disease 29.6 REN NPPB NPPA AGTR1 ACE
41 hyperglycemia 29.5 SOD1 NOS3 CAT AGTR1
42 coronary heart disease 1 29.5 NPPB NOS3 EDN1 AGTR1 ACE
43 malignant hypertension 29.2 REN NPPB NPPA EDN1 AGTR1 ADM
44 pulmonary edema 29.2 REN NPPB NPPA NOS3 HMOX1 EDN1
45 ischemia 29.2 SOD1 NPPB NOS3 NOS1 HMOX1 EDN1
46 vascular disease 28.8 SOD1 REN NPPB NOS3 HMOX1 EDN1
47 congestive heart failure 28.7 REN NPPB NPPA NOS3 EDN1 AGTR1
48 stroke, ischemic 28.6 REN NPPB NPPA NOS3 AGTR1 ADM
49 kidney disease 28.0 REN PKD1 NPPB NPPA NOS3 LCN2
50 pre-eclampsia 27.8 SOD1 REN NPPA NOS3 HMOX1 EDN1
51 diabetes mellitus 27.7 SOD1 REN NPPB NOS3 LCN2 HMOX1
52 chronic kidney disease 27.2 SOD1 REN PKD1 NPPB NPPA NOS3
53 diabetes mellitus, noninsulin-dependent 27.0 SOD1 REN NOS3 LCN2 JAK2 HMOX1
54 heart disease 26.9 REN NPPB NPPA NOS3 LCN2 HMOX1
55 hypertension, essential 26.1 SOD1 REN PKD1 NPR2 NPPB NPPA
56 myocardial infarction 26.1 REN NPR2 NPPB NPPA NOS3 NOS1
57 benign renovascular hypertension 12.5
58 nephrosclerosis 11.7
59 neurofibromatosis 10.8
60 takayasu arteritis 10.6
61 hypokalemia 10.5
62 aortitis 10.5
63 vasculogenic impotence 10.5 NPPA ACE
64 adrenal gland pheochromocytoma 10.5
65 orthostatic proteinuria 10.4 REN ACE
66 nephrotic syndrome 10.4
67 hypoaldosteronism 10.4 REN NPPA ACE
68 coarctation of aorta 10.4
69 aortic aneurysm 10.4
70 pure autonomic failure 10.4 REN NPPA ACE
71 moyamoya disease 1 10.4
72 glomerulonephritis 10.4
73 idiopathic hypercalciuria 10.4 REN NPPA EDN1
74 cholesterol embolism 10.4 REN ACE
75 aortic dissection 10.4
76 pyelonephritis 10.4
77 vasculitis 10.4
78 progressive muscular dystrophy 10.4 NPPA NOS1
79 aortic aneurysm, familial abdominal, 1 10.3
80 focal segmental glomerulosclerosis 10.3
81 atypical coarctation of aorta 10.3
82 cardiac tuberculosis 10.3 NPPB ACE
83 meningitis and encephalitis 10.3 SOD1 CAT
84 pyelitis 10.3 REN LCN2 ACE
85 testicular torsion 10.3 NOS3 CAT ACE
86 thrombosis 10.3
87 polyarteritis nodosa 10.3
88 aneurysm 10.3
89 encephalopathy 10.3
90 hepatopulmonary syndrome 10.3 NOS3 HMOX1 EDN1
91 acute cystitis 10.3 REN LCN2 ACE
92 toxic myocarditis 10.3 NPPB ACE
93 hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy 10.3
94 hydronephrosis 10.3
95 chronic thromboembolic pulmonary hypertension 10.3 NPPB EDN1
96 potter's syndrome 10.3 REN ACE
97 obstructive nephropathy 10.3 REN LCN2 ACE
98 silicosis 10.3 HMOX1 CAT ACE
99 anterolateral myocardial infarction 10.2 NPPB NPPA ACE
100 inappropriate adh syndrome 10.2 REN NPPB NPPA
101 left bundle branch hemiblock 10.2 REN NPPB ACE
102 polycystic kidney disease 1 with or without polycystic liver disease 10.2 REN PKD1 NOS3 ACE
103 cardiac tamponade 10.2 REN NPPB ACE
104 intracranial aneurysm 10.2 PKD1 NOS3 ACE
105 hypercholesterolemia, familial, 1 10.2
106 adenoma 10.2
107 horseshoe kidney 10.2
108 kidney papillary necrosis 10.2 REN ACE
109 diabetic neuropathy 10.2 REN CAT ACE
110 pericardium disease 10.2 REN NPPB ACE
111 pulmonary valve insufficiency 10.2 NPPB EDN1 ACE
112 chronic mountain sickness 10.2 NPPB NOS3 EDN1
113 malignant secondary hypertension 10.2 REN AGTR1
114 systemic lupus erythematosus 10.2
115 peripheral vascular disease 10.2
116 adrenal adenoma 10.2
117 myocarditis 10.2
118 47,xyy 10.2
119 autonomic dysfunction 10.2
120 extrinsic cardiomyopathy 10.2 REN NPPB ACE
121 tetrahydrobiopterin deficiency 10.2 SOD1 NOS3 NOS1
122 coronary artery vasospasm 10.2 NOS3 EDN1 CMA1 ACE
123 heart conduction disease 10.2 REN NPPB ACE
124 retinal ischemia 10.1 SOD1 HMOX1 CAT
125 vein disease 10.1 JAK2 EDN1 ACE
126 impotence 10.1 NOS3 NOS1 EDN1 ACE
127 varicocele 10.1 SOD1 NOS3 CAT
128 fibrosis of extraocular muscles, congenital, 1 10.1
129 marfan syndrome 10.1
130 neurofibromatosis, type i 10.1
131 williams-beuren syndrome 10.1
132 spastic paraplegia, intellectual disability, nystagmus, and obesity 10.1
133 renal fibrosis 10.1
134 fibrous dysplasia 10.1
135 renal hypoplasia 10.1
136 chronic pyelonephritis 10.1
137 hyperinsulinism 10.1
138 essential thrombocythemia 10.1
139 antiphospholipid syndrome 10.1
140 uremia 10.1
141 aortic disease 10.1
142 lupus erythematosus 10.1
143 aldosterone-producing adenoma 10.1
144 mitral valve stenosis 10.1 REN NPPB NPPA ACE
145 mitral valve insufficiency 10.1 REN NPPB NPPA ACE
146 acute chest syndrome 10.1 NOS3 NOS1 HMOX1 EDN1
147 pericardial effusion 10.1 REN NPPB NPPA ACE
148 severe nonproliferative diabetic retinopathy 10.1 REN ACE
149 tricuspid valve insufficiency 10.1 REN NPPB EDN1 ACE
150 tricuspid valve disease 10.1 REN NPPB EDN1 ACE
151 heart valve disease 10.1 REN NPPB NPPA ACE
152 intrinsic cardiomyopathy 10.1 REN NPPB NPPA ACE
153 hyperphenylalaninemia 10.1 SOD1 NOS1 CAT
154 aortic valve disease 2 10.1 REN NPPB NPPA ACE
155 familial hypertension 10.1 REN NPPA AGTR1
156 chronic pulmonary heart disease 10.1 NPPB NOS3 EDN1 ACE
157 twin-to-twin transfusion syndrome 10.1 REN NPPA AGTR1
158 renal tubular dysgenesis 10.1 REN AGTR1 ACE
159 polyhydramnios 10.1 REN NPPB EDN1
160 hepatorenal syndrome 10.1 REN NPPA LCN2 EDN1 ACE
161 toxic encephalopathy 10.1 SOD1 HMOX1 CAT
162 patent foramen ovale 10.1 REN NPPB EDN1 ACE
163 hepatic vascular disease 10.1 REN NOS3 JAK2 EDN1
164 iga glomerulonephritis 10.1 REN AGTR1 ACE
165 raynaud disease 10.0 EDN1 AGTR1 ACE
166 posterior urethral valves 10.0 AGTR1 ACE
167 atrial heart septal defect 10.0 NPPB NPPA EDN1 ACE
168 alagille syndrome 1 10.0
169 thrombophilia due to thrombin defect 10.0
170 renal hypodysplasia/aplasia 1 10.0
171 myasthenia gravis 10.0
172 polycythemia vera 10.0
173 hypertensive nephropathy 10.0
174 microvascular complications of diabetes 4 10.0
175 microvascular complications of diabetes 6 10.0
176 microvascular complications of diabetes 7 10.0
177 muscle hypertrophy 10.0
178 autoimmune vasculitis 10.0
179 exanthem 10.0
180 paraganglioma 10.0
181 extra-adrenal pheochromocytoma 10.0
182 scoliosis 10.0
183 cerebral artery occlusion 10.0
184 aortic atherosclerosis 10.0
185 hemiplegia 10.0
186 arteriovenous malformation 10.0
187 allergic hypersensitivity disease 10.0
188 ehlers-danlos syndrome 10.0
189 cholestasis 10.0
190 leiomyosarcoma 10.0
191 thrombocytosis 10.0
192 transient cerebral ischemia 10.0
193 lipomatosis 10.0
194 teratoma 10.0
195 systemic scleroderma 10.0
196 coronary stenosis 10.0
197 nephrolithiasis 10.0
198 thyroiditis 10.0
199 neuroblastoma 10.0
200 polycythemia 10.0
201 intermediate coronary syndrome 10.0
202 renal tuberculosis 10.0
203 median arcuate ligament syndrome 10.0
204 48,xyyy 10.0
205 cerebral aneurysms 10.0
206 pik3ca-related overgrowth syndrome 10.0
207 interstitial nephritis 10.0 REN AGTR1 ACE
208 iga nephropathy 1 10.0 AGTR1 ACE
209 hypoplastic left heart syndrome 10.0 NPPB NPPA LCN2 ACE
210 pulmonary embolism 10.0 NPPB NPPA ACE
211 central sleep apnea 10.0 REN NPPB NPPA NOS3 ACE
212 renal dysplasia 10.0 REN PKD1 AGTR1 ACE
213 sleep apnea 10.0 REN NPPB NOS3 EDN1 ACE
214 apnea, obstructive sleep 10.0 REN NPPB NOS3 EDN1 ACE
215 meningococcal infection 9.9 SOD1 AGTR1
216 acute mountain sickness 9.9 NOS3 EDN1 AGTR1 ACE
217 cerebral palsy 9.9 SOD1 NOS3 NOS1 CAT
218 anuria 9.9 REN LCN2 AGTR1 ACE
219 nonarteritic anterior ischemic optic neuropathy 9.9 NOS3 EDN1 AGTR1 ACE
220 cardiac conduction defect 9.9
221 beckwith-wiedemann syndrome 9.9
222 hypertriglyceridemia, familial 9.9
223 melorheostosis, isolated 9.9
224 hemifacial microsomia 9.9
225 nephrolithiasis, calcium oxalate 9.9
226 hutchinson-gilford progeria syndrome 9.9
227 supravalvular aortic stenosis 9.9
228 triiodothyronine receptor auxiliary protein 9.9
229 vater/vacterl association 9.9
230 ascites, chylous 9.9
231 chondrosarcoma 9.9
232 factor vii deficiency 9.9
233 pseudoxanthoma elasticum 9.9
234 wilms tumor 5 9.9
235 grange syndrome 9.9
236 homocysteinemia 9.9
237 ventricular fibrillation, paroxysmal familial, 1 9.9
238 cervical cancer 9.9
239 resting heart rate, variation in 9.9
240 mycobacterium tuberculosis 1 9.9
241 encephalocraniocutaneous lipomatosis 9.9
242 rasopathy 9.9
243 hydrocephalus 9.9
244 benign essential hypertension 9.9
245 retinal microaneurysm 9.9
246 neurogenic bladder 9.9
247 nephrocalcinosis 9.9
248 endomyocardial fibrosis 9.9
249 subclavian steal syndrome 9.9
250 dementia 9.9
251 severe pre-eclampsia 9.9
252 megaesophagus 9.9
253 diarrhea 9.9
254 hyperparathyroidism 9.9
255 facial paralysis 9.9
256 renal tubular acidosis 9.9
257 hypothyroidism 9.9
258 vacterl association 9.9
259 hyperuricemia 9.9
260 constipation 9.9
261 ectodermal dysplasia 9.9
262 gangliocytoma 9.9
263 angiodysplasia 9.9
264 acute pancreatitis 9.9
265 cystic kidney disease 9.9
266 testicular cancer 9.9
267 carotid artery disease 9.9
268 choriocarcinoma 9.9
269 intermittent claudication 9.9
270 cranial nerve palsy 9.9
271 intracranial thrombosis 9.9
272 melorheostosis 9.9
273 rapidly progressive glomerulonephritis 9.9
274 ganglioneuroma 9.9
275 pancreatitis 9.9
276 arteriolosclerosis 9.9
277 dystonia 9.9
278 adrenal neuroblastoma 9.9
279 paraplegia 9.9
280 b-cell lymphoma 9.9
281 ileus 9.9
282 chronic intestinal vascular insufficiency 9.9
283 neuropathy 9.9
284 rubella 9.9
285 amyloidosis 9.9
286 achalasia 9.9
287 speech disorder 9.9
288 erythromelalgia 9.9
289 homocystinuria 9.9
290 intracranial hypertension 9.9
291 primary ciliary dyskinesia 9.9
292 neurofibroma 9.9
293 kidney hypertrophy 9.9
294 placental abruption 9.9
295 triple x syndrome 9.9
296 congenital rubella 9.9
297 craniofacial microsomia 9.9
298 cytokine deficiency 9.9
299 erythrokeratoderma ''en cocardes'' 9.9
300 germ cells tumors 9.9
301 glioma 9.9
302 medullary sponge kidney 9.9
303 nephrogenic systemic fibrosis 9.9
304 parkes weber syndrome 9.9
305 retroperitoneal fibrosis 9.9
306 splenomegaly 9.9
307 weber syndrome 9.9
308 headache 9.9
309 hypotonia 9.9
310 hypoxia 9.9
311 spinal cord injury 9.9
312 glial tumor 9.9
313 rapidly involuting congenital hemangioma 9.9
314 specific language disorder 9.9
315 cyanide poisoning 9.9
316 congenital renal artery stenosis 9.9
317 thrombotic microangiopathy 9.9
318 overgrowth syndrome 9.9
319 congenital arteriovenous fistula 9.9
320 vesicoureteral reflux 1 9.9 REN LCN2 AGTR1 ACE
321 acute pyelonephritis 9.8 LCN2 ADM ACE
322 first-degree atrioventricular block 9.8 NPPB ACE
323 microvascular complications of diabetes 5 9.8 SOD1 NOS3 AGTR1 ACE
324 endocrine organ benign neoplasm 9.8 REN NF1 ADM
325 ureteral disease 9.7 REN LCN2 HMOX1 AGTR1 ACE
326 aortic valve disease 1 9.7 REN NOS3 EDN1 AGTR1 ACE
327 diabetes mellitus, type i 9.7 REN NPPA NOS3 AGTR1 ACE
328 lung disease 9.7 SOD1 NPPB HMOX1 EDN1 ACE
329 diabetic angiopathy 9.7 NOS3 EDN1 CAT ADM
330 systolic heart failure 9.7 NPPB NPPA NOS3 EDN1 CMA1 ACE
331 orthostatic intolerance 9.6 REN PKD1 NOS3 EDN1 AGTR1 ACE
332 liver cirrhosis 9.6 REN NPPA EDN1 ADM
333 portal hypertension 9.6 NOS3 JAK2 EDN1 AGTR1 ACE
334 diastolic heart failure 9.5 REN NPPB NPPA NOS3 AGTR1 ACE
335 mitral valve disease 9.5 REN NPPB NPPA NOS3 AGTR1 ACE
336 atrial fibrillation 9.5 REN NPPB NPPA NOS3 AGTR1 ACE
337 idiopathic edema 9.5 NPPB NPPA EDN1 ADM ACE
338 intracranial berry aneurysm 9.5 REN PKD1 NOS3 HMOX1 EDN1 ADM
339 myocardial stunning 9.5 SOD1 NOS3 EDN1 CAT AGTR1 ACE
340 autosomal dominant polycystic kidney disease 9.4 REN PKD1 NOS3 LCN2 EDN1 AGTR1
341 polycystic kidney disease 9.4 REN PKD1 NOS3 LCN2 EDN1 AGTR1
342 migraine with or without aura 1 9.4 REN NOS3 NOS1 EDN1 ADM ACE
343 deficiency anemia 9.4 SOD1 NPPA LCN2 JAK2 HMOX1 CAT
344 hypertrophic cardiomyopathy 9.3 REN NPPB NPPA NOS3 EDN1 AGTR1
345 body mass index quantitative trait locus 11 9.1 REN NOS3 NOS1 LCN2 JAK2 HMOX1
346 oligohydramnios 9.0 REN NPPB EDN1 AGTR1 ADM ACE
347 malaria 9.0 SOD1 NOS3 LCN2 HMOX1 EDN1 CAT
348 acute myocardial infarction 8.9 REN NPPB NPPA EDN1 AGTR1 ADM
349 respiratory failure 8.9 SOD1 REN NPPB NPPA EDN1 CAT
350 tetralogy of fallot 8.9 SOD1 REN NPPB NPPA EDN1 CAT
351 lipoprotein quantitative trait locus 8.7 REN NPPB NPPA NOS3 EDN1 AGTR1
352 pulmonary hypertension 8.5 REN NPPB NPPA NOS3 HMOX1 EDN1
353 asthma 8.4 NPPA NOS1 JAK2 EDN1 CMA1 CAT
354 cardiovascular system disease 8.1 SOD1 REN NPPB NPPA NOS3 HMOX1
355 dilated cardiomyopathy 8.0 SOD1 REN NPPB NPPA NOS3 HMOX1

Graphical network of the top 20 diseases related to Renovascular Hypertension:



Diseases related to Renovascular Hypertension

Symptoms & Phenotypes for Renovascular Hypertension

MGI Mouse Phenotypes related to Renovascular Hypertension:

45 (showing 13, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.39 ACE ADM AGTR1 EDN1 HMOX1 JAK2
2 hematopoietic system MP:0005397 10.36 ACE ADM AGTR1 CMA1 HMOX1 JAK2
3 homeostasis/metabolism MP:0005376 10.36 ACE ADM AGTR1 CAT EDN1 HMOX1
4 growth/size/body region MP:0005378 10.29 ACE AGTR1 EDN1 HMOX1 JAK2 LCN2
5 immune system MP:0005387 10.28 ACE ADM AGTR1 CMA1 HMOX1 JAK2
6 endocrine/exocrine gland MP:0005379 10.27 ACE ADM EDN1 HMOX1 JAK2 LCN2
7 mortality/aging MP:0010768 10.2 ACE ADM AGTR1 CAT EDN1 HMOX1
8 adipose tissue MP:0005375 10.07 ACE AGTR1 HMOX1 LCN2 NOS1 NOS3
9 liver/biliary system MP:0005370 10.07 ACE ADM HMOX1 JAK2 LCN2 NF1
10 muscle MP:0005369 10 ADM EDN1 HMOX1 NF1 NOS1 NOS3
11 renal/urinary system MP:0005367 9.97 ACE ADM AGTR1 EDN1 HMOX1 LCN2
12 reproductive system MP:0005389 9.73 ACE ADM HMOX1 JAK2 LCN2 NF1
13 respiratory system MP:0005388 9.23 ADM HMOX1 JAK2 NF1 NOS1 NOS3

Drugs & Therapeutics for Renovascular Hypertension

Drugs for Renovascular Hypertension (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 38, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 4
2
Aspirin Approved, Vet_approved Phase 3 50-78-2 2244
3
Angiotensin II Approved, Investigational Phase 3 4474-91-3, 11128-99-7, 68521-88-0 172198
4
Candesartan cilexetil Approved Phase 3 145040-37-5 2540
5
Paclitaxel Approved, Vet_approved Phase 3 33069-62-4 36314
6
Candesartan Experimental Phase 3 139481-59-7 2541
7 Fibrinolytic Agents Phase 3
8 Analgesics, Non-Narcotic Phase 3
9 Analgesics Phase 3
10 Cyclooxygenase Inhibitors Phase 3
11 Platelet Aggregation Inhibitors Phase 3
12 Antipyretics Phase 3
13 Anti-Inflammatory Agents Phase 3
14 Antirheumatic Agents Phase 3
15 Anti-Inflammatory Agents, Non-Steroidal Phase 3
16 Angiotensin Receptor Antagonists Phase 3
17 Antihypertensive Agents Phase 3
18 Angiotensin II Type 1 Receptor Blockers Phase 3
19 Angiotensinogen Phase 3
20 Giapreza Phase 3
21 Amlodipine, atorvastatin drug combination Phase 3
22 Albumin-Bound Paclitaxel Phase 3
23 Tubulin Modulators Phase 3
24 Antimitotic Agents Phase 3
25
Heparin Approved, Investigational 9005-49-6 46507594 772
26
Lidocaine Approved, Vet_approved 137-58-6 3676
27
Bevacizumab Approved, Investigational 216974-75-3
28
Epoprostenol Approved 35121-78-9, 61849-14-7 5282411 5280427
29
Sunitinib Approved, Investigational 557795-19-4, 341031-54-7 5329102
30
Cediranib Investigational 288383-20-0 9933475
31 Tezosentan Investigational 180384-57-0
32 Pharmaceutical Solutions
33 Anesthetics
34 Anesthetics, Local
35 calcium heparin
36 Angiogenesis Inhibitors
37 Angiotensin-Converting Enzyme Inhibitors
38 Anticholesteremic Agents

Interventional clinical trials:

(showing 20, show less)
# Name Status NCT ID Phase Drugs
1 Phase 4 Study of Medical Therapy Versus Medical Therapy Plus Renal Artery Stenting in Preventing the Progression of Renal Failure in Atherosclerotic Renovascular Disease Unknown status NCT01023373 Phase 4 Medical treatment
2 Percutaneous Renal Stenting in Renovascular Disease With or Without Distal Atheroembolic Protection Unknown status NCT00868972 Phase 2, Phase 3
3 Effect of Aspirin on Renal Disease Progression in Patients With Type 2 Diabetes: a Multicentre Double-blind, Placebo-controlled, Randomised Trial. The LEDA (renaL disEase Progression by Aspirin in Diabetic pAtients) Study. Unknown status NCT02895113 Phase 3 Aspirin
4 Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) Completed NCT00081731 Phase 3 Atacand/HCT, Caduet
5 Comparison of Drug-eluting Balloon and Plain Balloon for Treatment of Non-atherosclerotic Renal Artery Stenosis: a Randomized Controlled Study Recruiting NCT04366596 Phase 3
6 A Phase 2a, Randomized, Placebo-controlled, Single Center Trial to Evaluate the Impact of Intravenous Bendavia™ (MTP-131) on Ischemia Reperfusion Injury in Atherosclerotic Renal Artery Stenosis in Patients Undergoing Percutaneous Transluminal Angioplasty of the Renal Artery (PTRA) Terminated NCT01755858 Phase 1, Phase 2 Bendavia;Placebo
7 Phase I Study of Autologous Mesenchymal Stem Cells in the Treatment of Atherosclerotic Renal Artery Stenosis Completed NCT01840540 Phase 1 Arterial infusion of autologous mesenchymal stem cells
8 Evidence of Procedural Embolism Complicating Renal Artery Stenting Completed NCT00027469 Phase 1
9 Hypoxia and Inflammatory Injury in Human Renovascular Hypertension : Phase 1 Trial of Mesenchymal Stem Cell Therapy Active, not recruiting NCT02266394 Phase 1 Mesenchymal stem cell
10 Cardiovascular, Renal and Metabolic Profile in Patients With Acute Myocardial Infarction (AMI) Included in the Romanian National Programme of Primary Percutaneous Revascularisation - a Single Center Observational Study Unknown status NCT02388139
11 The Role of VEGF-A Signaling in Maintenance of the Glomerular Filtration Barrier and Blood Pressure Unknown status NCT00691730
12 Renal Atherosclerotic Revascularization Evaluation: RAVE Study Completed NCT00127738
13 REFORM Clinical Study: Treatment of Renal Artery Stenosis With the Formula Balloon-Expandable Stent Completed NCT00631540
14 Assessment of Renal Artery Stenosis and Renovascular Hypertension by Contrast Enhanced Magnetic Resonance Imaging: A Pilot Study Completed NCT00006173
15 PROgression of FIbromuscular LEsions Completed NCT02961868
16 Assessment of Renal and Cervical Artery DysplasIA Completed NCT02884141
17 A Prospective Danish National Registry of Percutaneous Transluminal Renal Angioplasty in Patients With Renovascular Hypertension Recruiting NCT02770066
18 ARTISAN: iCAST™ RX De Novo Stent Placement for the Treatment of Atherosclerotic Renal Artery Stenosis in Patients With Resistant Hypertension Active, not recruiting NCT01673373
19 Kidney Transplantation and Renal and Myocardial Perfusion Active, not recruiting NCT02960802
20 A Multicenter Registry of Endovascular Therapy for Renal Artery Stenosis in China Not yet recruiting NCT03080519

Search NIH Clinical Center for Renovascular Hypertension

Inferred drug relations via UMLS 71 / NDF-RT 50 :


Fenoldopam
Fenoldopam Mesylate

Cochrane evidence based reviews: hypertension, renovascular

Genetic Tests for Renovascular Hypertension

Anatomical Context for Renovascular Hypertension

MalaCards organs/tissues related to Renovascular Hypertension:

40
Kidney, Testes, Heart, Endothelial, Brain, Smooth Muscle, Cortex

Publications for Renovascular Hypertension

Articles related to Renovascular Hypertension:

(showing 4945, show less)
# Title Authors PMID Year
1
Divergences in antihypertensive therapy in special situations in nephrology. 54 61
18425285 2008
2
Pre-operative renal function and selective renal vein renin levels as markers of favourable outcome in renovascular hypertension. 54 61
18062531 2007
3
Pre-operative renal function and selective renal vein renin levels as markers of favourable outcome in renovascular hypertension. 61 54
17489524 2007
4
Assessment of renal artery stenosis severity by pressure gradient measurements. 61 54
17084261 2006
5
Reversible renin-dependent renovascular hypertension successfully treated with percutaneous transluminal renal angioplasty and stenting. 54 61
15876819 2005
6
Renovascular hypertension. 61 54
15695858 2005
7
[Should renal vein catheterization for selective renin determination be performed in patients with suspected renovascular hypertension?]. 61 54
15515466 2004
8
Plasma adrenomedullin concentrations in patients with renovascular or malignant hypertension. 54 61
15284680 2004
9
Encapsulated transgene cells attenuate hypertension, cardiac hypertrophy and enhance renal function in Goldblatt hypertensive rats. 54 61
15241786 2004
10
Six missense mutations of the epithelial sodium channel beta and gamma subunits in Japanese hypertensives. 54 61
15198480 2004
11
Cyclooxygenase-2 up-regulation in reflux nephropathy. 54 61
14501677 2003
12
NT-proANP and BNP in renovascular and in severe and mild essential hypertension. 54 61
12697975 2003
13
Phase-contrast magnetic resonance flow quantification in renal arteries: comparison with 133Xenon washout measurements. 54 61
12511539 2003
14
Renal vein renin measurements accurately identify renovascular hypertension caused by total occlusion of the renal artery. 54 61
12011659 2002
15
On the significance of renal vein renins in renovascular hypertension. 61 54
12011641 2002
16
Treatment options for renovascular hypertension. 54 61
11934344 2002
17
Hypertension and renovascular disease: follow-up on 100 renal vein renin samplings. 61 54
11967722 2002
18
ACE inhibition is superior to angiotensin receptor blockade for renography in renal artery stenosis. 54 61
12002704 2002
19
Angiotensin I-converting enzyme gene polymorphism influences chronic hypertensive response in the rat Goldblatt model. 61 54
11875308 2002
20
The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism? 54 61
11791020 2002
21
[Nephrourology and nuclear medicine today]. 54 61
11512405 2001
22
Prostaglandin I(2)/E(2) ratios in unilateral renovascular hypertension of different severities. 61 54
11463755 2001
23
Adrenomedullin gene delivery attenuates renal damage and cardiac hypertrophy in Goldblatt hypertensive rats. 54 61
11352835 2001
24
[Converting enzyme inhibitors in the diagnosis of secondary arterial hypertension --focus on the captopril test]. 54 61
11301909 2000
25
The pathophysiology of renin release in renovascular hypertension. 61 54
11022891 2000
26
Functional testing: renin studies. 61 54
11022895 2000
27
Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. 61 54
10930193 2000
28
Specific direct radioimmunoassay of angiotensin II (AT II) in human plasma and the effect of angiotensin converting enzyme (ACE) inhibitor. 54 61
10604545 1999
29
ACE inhibition scintigraphy in the management of hypertension in children. 61 54
10452277 1999
30
Radionuclide renography: a personal approach. 61 54
10321824 1999
31
Short-term modulation of the renin-angiotensin system does not alter plasma adrenomedullin concentration in humans. 61 54
9886897 1998
32
[Current pharmaco-therapeutic strategies in the treatment of arterial hypertension]. 54 61
9813738 1998
33
Endothelin and active renin levels in essential hypertension and hypertension with renal artery stenosis before and after percutaneous transluminal renal angioplasty. 61 54
9488241 1997
34
[Nuclear nephrology]. 61 54
9494337 1997
35
Renovascular hypertension with low-to-normal plasma renin: clinical and angiographic features. 54 61
9486089 1997
36
Plasma endothelin-1 level in patients with renovascular hypertension - does the kidney with stenosis of the renal artery upregulate production of endthelin-1? 54 61
9233908 1997
37
Consensus report on ACE inhibitor renography for detecting renovascular hypertension. Radionuclides in Nephrourology Group. Consensus Group on ACEI Renography. 54 61
8917196 1996
38
Renal extraction of atrial natriuretic peptide in hypertensive patients with or without renal artery stenosis. 54 61
8641732 1996
39
[Comparison of captopril angioscintigraphy and the renin test in diagnosis of renovascular hypertension]. 61 54
8755852 1996
40
Acute blockage of the renin system and differential renal vein renin determinations in the diagnosis of renovascular hypertension. 61 54
8727869 1996
41
Renovascular hypertension in blacks. 54 61
8834702 1996
42
Reversible nephrotic syndrome due to high renin state in renovascular hypertension. 54 61
7731487 1995
43
Effect of chronic ACE inhibition on the diagnostic value of renography for renovascular hypertension: a preliminary report. 61 54
7753462 1995
44
Regulation of the structural remodelling of the myocardium: from hypertrophy to heart failure. 54 61
7713113 1994
45
[Renal ablation by transcatheter renal arterial embolization in the treatment of benign renal disease]. 61 54
9261190 1994
46
Response to the captopril test is dependent on baseline renin profile. 61 54
8021469 1994
47
Captopril-stimulated renal vein renin measurements in the diagnosis of atherosclerotic renovascular hypertension. 61 54
8136101 1994
48
Renin secretion and captopril stimulation in hypertensive renal transplant recipients. 54 61
8178382 1994
49
Scintigraphic evaluation of renovascular hypertension. 61 54
8128734 1993
50
[Evaluation criteria for captopril-kidney function scintigraphy using 99mTc-MAG3]. 54 61
8295828 1993
51
Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant nephropathy. 54 61
8216441 1993
52
Diagnosis of renovascular hypertension with ACE inhibition scintigraphy. 61 54
8337370 1993
53
Reliability of ACE inhibitor-enhanced 99Tcm-DTPA gamma camera renography in the detection of renovascular hypertension. 61 54
8455906 1993
54
Renin-angiotensin system and myocardial collagen matrix remodeling in hypertensive heart disease: in vivo and in vitro studies on collagen matrix regulation. 54 61
8518539 1993
55
Renal and systemic sympathetic counterregulation in response to vasodilators in renovascular hypertension. 54 61
8382132 1993
56
[Usefulness of converting enzyme inhibitors in the diagnosis of arterial hypertension]. 61 54
1299939 1992
57
[For which hypertensive patient should angiotensin-converting enzyme inhibitor be prescribed or forbidden?]. 54 61
1299938 1992
58
In vivo and in vitro effects of atrial natriuretic peptide on renin release. 54 61
1424300 1992
59
Effects of atrial natriuretic factor on patients with renovascular hypertension. 54 61
1288975 1992
60
Treatment of neonatal renovascular hypertension with intravenous enalapril. 54 61
1627214 1992
61
Blood pressure, angiotensin-converting enzyme (ACE) inhibitors, and the kidney. 54 61
1580276 1992
62
Hypertension in elderly patients. The special concerns in this growing population. 61 54
1546024 1992
63
Renal effects of antihypertensive agents in parenchymal renal disease and renovascular hypertension. 54 61
1382165 1992
64
L-arginine as an antihypertensive agent. 54 61
1282968 1992
65
Effect of aging on the renin angiotensin system in patients with renovascular hypertension. 61 54
1619967 1992
66
Systemic and renovascular hypertension. 61 54
1412441 1992
67
ACE inhibitors in the diagnosis of renovascular hypertension. 54 61
1730791 1992
68
Plasma erythropoietin concentrations in renal venous blood of patients with unilateral renovascular hypertension. 61 54
1314993 1992
69
Aldosteronoma coexisting with renal artery stenosis in secondary hypertension. 54 61
1598748 1992
70
The effect of caffeine on renal vein renin concentration in patients with renal arterial disease. 61 54
1815652 1991
71
Suppression of renal vein renin profiles by mannitol prophylaxis: implications in the evaluation of renovascular hypertension. 54 61
1962648 1991
72
Peripheral and renal vein renin activity in patients with renovascular hypertension due to nonspecific aortoarteritis. 54 61
1763831 1991
73
[Initial experiences in nuclear medicine and endocrine diagnosis with captopril in unilateral renal artery stenosis]. 61 54
1796619 1991
74
Aspirin test for differentiation of unilateral renovascular hypertension from hyperreninemic essential hypertension. 54 61
1930860 1991
75
Angiotensin converting enzyme (ACE) inhibitors and renal function. A review of the current status. 54 61
1930742 1991
76
[Use of intravenous nicardipine for the diagnosis of renovascular hypertension]. 54 61
1953265 1991
77
[Hypertension from the nephrologist's point of view]. 61 54
1837418 1991
78
[Captopril renography in the diagnosis of renovascular hypertension]. 54 61
2058027 1991
79
Norepinephrine overflow and renin pattern of the individual kidney in patients with unilateral renal artery stenosis. 61 54
1646164 1991
80
Similar prevalence of renovascular hypertension in selected blacks and whites. 61 54
2022411 1991
81
Screening for renovascular hypertension. 61 54
1827206 1991
82
Renal vein renins: inability to predict response to revascularization in patients with hypertension. 61 54
1994424 1991
83
Captopril-stimulated renal vein renin in hypertensive patients with or without renal artery stenosis. 61 54
2081013 1990
84
Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects. 54 61
2220796 1990
85
Low-dose captopril scintigraphy in the evaluation of renovascular hypertension. 61 54
2200626 1990
86
Angiotensin-converting enzyme inhibitors and renal function. 61 54
2188438 1990
87
Hemodynamic and renin responses to nifedipine in renovascular hypertension. 61 54
2405611 1990
88
ACE inhibitors in renovascular hypertension. 61 54
2285615 1990
89
Angiotensin-converting enzyme inhibitor induced angioedema of the head and neck. 54 61
2085001 1990
90
Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat. 54 61
2299253 1990
91
Systemic administration of pentoxifylline attenuates the development of hypertension in renovascular hypertensive rats. 61
32060380 2020
92
Recent Innovations in Renal Vascular Imaging. 61
32471544 2020
93
Genetics of renovascular hypertension in children. 61
32516295 2020
94
[Renovascular hypertension secondary to Takayasu arteritis]. 61
32564975 2020
95
How should we define appropriate patients for percutaneous transluminal renal angioplasty treatment? 61
32572170 2020
96
Mid-Aortic Syndrome: A Rare Cause of Renovascular Hypertension in Childhood Treated Percutaneously with an Unusual Vascular Access. 61
32516103 2020
97
Nephrotic syndrome and Giant cell arthritis concurrently occurring after percutaneous transluminal angioplasty for renal artery stenosis
. 61
32213283 2020
98
Renovascular hypertension secondary to renal artery compression by diaphragmatic crura. 61
32490294 2020
99
Aliskiren improves renal morphophysiology and inflammation in Wistar rats with 2K1C renovascular hypertension. 61
31625581 2020
100
"Complex aortic, visceral and renal arteries reconstruction with a four branched Dacron graft for Middle Aortic Syndrome secondary to Takayasu´s Arteritis". 61
32534020 2020
101
Fitness is improved by adjustments in muscle intracellular signaling in rats with renovascular hypertension 2K1C undergoing voluntary physical exercise. 61
32179073 2020
102
Molecular genetics of human hypertension. 61
32068615 2020
103
Excessive dietary salt promotes aortic stiffness in murine renovascular hypertension. 61
32302491 2020
104
Pediatric Renovascular Hypertension: Manifestations and Management. 61
32221053 2020
105
Recent advances in nanotechnology-based drug delivery systems for the kidney. 61
32067996 2020
106
Dietary capsaicin-mediated attenuation of hypertension in a rat model of renovascular hypertension. 61
31518162 2020
107
Interaction between angiotensin II and GABA in the spinal cord regulates sympathetic vasomotor activity in Goldblatt hypertension. 61
32304717 2020
108
Fetal congenital midaortic syndrome with unilateral renal artery stenosis prenatally presenting with polyhydramnios and postpartum as hyponatremic hypertensive syndrome. 61
32444441 2020
109
Postoperative Symptomatic Cerebral Infarction in Pediatric Moyamoya Disease: Risk Factors and Clinical Outcome. 61
31870818 2020
110
Renal Artery Stenosis As Etiology of Recurrent Flash Pulmonary Edema and Role of Imaging in Timely Diagnosis and Management. 61
32399343 2020
111
Surgical Management of Pediatric renin-mediated Hypertension seCONDARY TO RENAL ARTERY OCCLUSIVE DISEASE AND ABDOMINAL AORTIC COARCTATION. 61
32276020 2020
112
Histologic and morphologic character of pediatric renal artery occlusive disease. 61
32276022 2020
113
Correlations Between Interleukin-11 Expression and Hypertensive Kidney Injury in a Rat Model of Renovascular Hypertension. 61
31840157 2020
114
Renovascular hypertension from the BCR-ABL tyrosine kinase inhibitor ponatinib. 61
32175644 2020
115
Response to: Parkes Weber syndrome: associated renovascular hypertension? 61
31274166 2020
116
Renovascular hypertension elevates pulmonary ventilation in rats by carotid body-dependent mechanisms. 61
32022595 2020
117
Collagen IV, a promising serum biomarker for evaluating the prognosis of revascularization in a 2-kidney, 1-clip hypertensive rat model. 61
31725159 2020
118
Afferent innervation of the ischemic kidney contributes to renal dysfunction in renovascular hypertensive rats. 61
31925527 2020
119
A simple refined approach for renovascular hypertension in children: a ten-year experience. 61
32153091 2020
120
The role of afferent renal denervation in renovascular hypertension-another brick in the wall. 61
32025813 2020
121
Verapamil decreases calpain-1 and matrix metalloproteinase-2 activities and improves hypertension-induced hypertrophic cardiac remodeling in rats. 61
31830479 2020
122
Ligustrazine prevents basilar artery remodeling in two-kidney-two-clip renovascular hypertension rats via suppressing PI3K/Akt signaling. 61
31682800 2020
123
Efficacy of Antihypertensive Therapy in a Child with Unilateral Focal Fibromuscular Dysplasia of the Renal Artery: A Case Study and Review of Literature. 61
32093171 2020
124
A boy with Alagille syndrome coexisting with mid-aortic syndrome and renovascular hypertension. 61
31933703 2020
125
Renovascular Hypertension: Novel Insights. 61
31038069 2020
126
Unexpected presentation and surgical salvage of transplant renal artery dissection caused by vascular clamping: a case report. 61
31996160 2020
127
Renal artery stenosis presenting as preeclampsia. 61
32257378 2020
128
Spontaneous Renal Artery Dissection in a Man with Previous Spontaneous Superior Mesenteric Artery Dissection. 61
32095311 2020
129
Secondary Hypertension: Novel Insights. 61
31038070 2020
130
[Percutaneous angioplasty of renal artery stenosis: Short- and long-term results]. 61
31761304 2019
131
Renovascular Hypertension. 61
31655775 2019
132
The Demystification of Secondary Hypertension: Diagnostic Strategies and Treatment Algorithms. 61
31823067 2019
133
Rediscovering Renovascular Hypertension. 61
31656097 2019
134
Renovascular hypertension: The current approach. 61
32139201 2019
135
Disruption of P2X4 purinoceptor and suppression of the inflammation associated with cerebral aneurysm formation. 61
31860812 2019
136
The need for clinical judgement in the application of evidence-based medicine. 61
31806620 2019
137
High prevalence of systemic hypertension in pediatric patients with moyamoya disease years after surgical treatment. 61
31703203 2019
138
Ask-Upmark Kidney, Imaging Features. 61
31880582 2019
139
Tissue-specific transcriptional regulation of epithelial/endothelial and mesenchymal markers during renovascular hypertension. 61
31702037 2019
140
Surgical management of renovascular hypertension in children and young adults: a 13-year experience. 61
31651975 2019
141
Successful Kidney Transplantation Using a Deceased Donor Graft With Fibromuscular Dysplasia. 61
31526531 2019
142
Diagnostic Role of Renal Doppler Ultrasound and Plasma Renin Activity as Screening Tools for Renovascular Hypertension in Children. 61
30779189 2019
143
Hemorrhagic stroke and renovascular hypertension with Grange syndrome arising from a novel pathogenic variant in YY1AP1. 61
31270375 2019
144
Image focus: renovascular hypertension. 61
31536466 2019
145
Melatonin stabilizes rupture-prone vulnerable plaques via regulating macrophage polarization in a nuclear circadian receptor RORα-dependent manner. 61
31009101 2019
146
Sex-related differences in the intratubular renin-angiotensin system in two-kidney, one-clip hypertensive rats. 61
31339773 2019
147
Effect of chrysanthemum extract on myocardial fibrosis in rats with renovascular hypertension. 61
32186102 2019
148
A case report of successfully treated nephrotic syndrome after renal angioplasty. 61
31387536 2019
149
Value of the Filtration Fraction Assessed by Dynamic 99mTc-Diethylenetriaminepentaacetic Acid Renal Scintigraphy After Angiotensin-Converting Enzyme Inhibition for the Diagnosis of Renovascular Hypertension. 61
31456860 2019
150
Usefulness of Renal Autotransplantation for Radiotherapy-induced Renovascular Hypertension. 61
30799345 2019
151
Urinary mitochondrial DNA copy number identifies renal mitochondrial injury in renovascular hypertensive patients undergoing renal revascularization: A Pilot Study. 61
30803138 2019
152
Brain functions and unusual β-amyloid accumulation in the hypertensive white matter lesions of rats. 61
31389227 2019
153
Kissing stent management of stenosis of two branches of left renal artery bifurcation: a case report. 61
31248449 2019
154
Senescent Kidney Cells in Hypertensive Patients Release Urinary Extracellular Vesicles. 61
31433703 2019
155
Losartan metabolite EXP3174 reduces the weight of formed thrombus in 2K1C hypertensive rats. 61
31566190 2019
156
Effect of Prolonged Infusion of Alamandine on Cardiovascular Parameters and Cardiac ACE2 Expression in a Rat Model of Renovascular Hypertension. 61
30956259 2019
157
The cardiovascular phenotype of childhood hypertension: a cardiac magnetic resonance study. 61
31053874 2019
158
Mechanisms underlying the effects of renal denervation in renovascular hypertension. 61
30796370 2019
159
Importance of the commissural nucleus of the solitary tract in renovascular hypertension. 61
30622315 2019
160
Tumour necrosis factor α sets area postrema on fire in renovascular hypertension. 61
30657874 2019
161
Bone marrow mononuclear cell transplantation rescues the glomerular filtration barrier and epithelial cellular junctions in a renovascular hypertension model. 61
30790372 2019
162
In renovascular hypertension, TNF-α type-1 receptors in the area postrema mediate increases in cardiac and renal sympathetic nerve activity and blood pressure. 61
30358805 2019
163
Is the commissural nucleus of the solitary tract essential for the maintenance of renovascular hypertension? A putative role for the carotid bodies. 61
30787444 2019
164
Renal denervation reduces sympathetic overactivation, brain oxidative stress, and renal injury in rats with renovascular hypertension independent of its effects on reducing blood pressure. 61
30573809 2019
165
Hematological indices in renovascular hypertension: A propensity score matching analysis. 61
30982819 2019
166
Nephrotic range proteinuria and metabolic alkalosis in Takayasu arteritis. 61
30992286 2019
167
The Modern Landscape of Renal Artery Stenosis and Renovascular Hypertension. 61
30904134 2019
168
Is there still a role for renal artery stenting in the management of renovascular hypertension - A single-center experience and where do we stand? 61
29934065 2019
169
A postzygotic KRAS mutation in a patient with Schimmelpenning syndrome presenting with lipomatosis, renovascular hypertension, and diabetes mellitus. 61
30443000 2019
170
Complex interventions of abdominal aorta and its branches in children with Takayasu arteritis: Clinical experience from a tertiary care center in north-west India. 61
30398008 2019
171
Naringenin Ameliorates Renovascular Hypertensive Renal Damage by Normalizing the Balance of Renin-Angiotensin System Components in Rats. 61
31217731 2019
172
Total arch replacement for aortic arch aneurysm with coexisting middle aortic syndrome. 61
30544040 2019
173
Renovascular Hypertension Aggravates Atherosclerosis in Cholesterol-Fed Rabbits. 61
30947215 2019
174
Systemic hypertension followed by insidious stroke in a 12-year-old boy with childhood neurofibromatosis type 1 presenting with renal and cerebral artery vasculopathy. 61
31990487 2019
175
Beneficial Effects of the Angiotensin-Converting Enzyme 2 Activator Dize in Renovascular Hypertension. 61
30950337 2019
176
Impact of Serum Uric Acid Levels on Outcomes following Renal Artery Revascularization in Patients with Renovascular Disease. 61
30838132 2019
177
Orexin Receptor-1 in the Rostral Ventrolateral Medulla Mediates the Antihypertensive Effects of Electroacupuncture. 61
30971886 2019
178
Exercise Training Attenuates Hypertension Through TLR4/MyD88/NF-κB Signaling in the Hypothalamic Paraventricular Nucleus. 61
31708733 2019
179
Outcome following renal autotransplantation in renal artery stenosis. 61
30787570 2019
180
Treatment with Mesenchymal Stem Cells Improves Renovascular Hypertension and Preserves the Ability of the Contralateral Kidney to Excrete Sodium. 61
31671420 2019
181
Parental Renovascular Hypertension-Induced Autonomic Dysfunction in Male Offspring Is Improved by Prenatal or Postnatal Treatment With Hydrogen Sulfide. 61
31607943 2019
182
Rationale and study design for one-stop assessment of renal artery stenosis and renal microvascular perfusion with contrast-enhanced ultrasound for patients with suspected renovascular hypertension. 61
30628960 2019
183
Long-Term Outcomes of Endovascular Stenting for Blunt Renal Artery Injuries with Stenosis: A Report of Five Consecutive Cases. 61
31292329 2019
184
Central Inhibition of Tumor Necrosis Factor Alpha Reduces Hypertension by Attenuating Oxidative Stress in the Rostral Ventrolateral Medulla in Renovascular Hypertensive Rats. 61
31114507 2019
185
Treatment of Renal Artery Stenosis in a Solitary Kidney Using Cutting Balloon Angioplasty in a Paediatric Patient. 61
30792585 2019
186
Takayasu Arteritis Presenting as Renovascular Hypertension. 61
30570491 2018
187
Redox regulation and NO/cGMP plus K+ channel activation contributes to cardiorenal protection induced by Cuphea carthagenensis (Jacq.) J.F. Macbr. in ovariectomized hypertensive rats. 61
30466630 2018
188
Calcium channel blockers are associated with improved survival and lower cardiovascular mortality in patients with renovascular disease. 61
30372589 2018
189
Renal autotransplantation for the management of renal artery in-stent restenosis in an adult patient with Takayasu arteritis. 61
30413449 2018
190
Mosaic KRAS mutation in a patient with encephalocraniocutaneous lipomatosis and renovascular hypertension. 61
30289595 2018
191
The Rise and Decline of Diagnostic Angiography for Renovascular Hypertension: A Memoir. 61
30274860 2018
192
Control of renal sympathetic nerve activity by neurotransmitters in the spinal cord in Goldblatt hypertension. 61
29935157 2018
193
Atypical Variant of Posterior Reversible Encephalopathy Syndrome in the Setting of Renovascular Hypertension: Case Report and Review of Literature. 61
30656077 2018
194
Takayasu Arteritis Presenting as Renovascular Hypertension and Renal Failure in a Patient with Factor VII Deficiency. 61
30515046 2018
195
Diuretic herb Gomphrena celosioides Mart. (Amaranthaceae) promotes sustained arterial pressure reduction and protection from cardiac remodeling on rats with renovascular hypertension. 61
29842964 2018
196
Arterial reconstructions for pediatric splanchnic artery occlusive disease. 61
29622358 2018
197
Moderate-intensity exercise and renin angiotensin system blockade improve the renovascular hypertension (2K1C)-induced gastric dysmotility in rats. 61
30170073 2018
198
Fibromuscular Dysplasia: Another Paradigm Shift in Renovascular Hypertension? 61
29709956 2018
199
Imaging studies in pediatric fibromuscular dysplasia (FMD): a single-center experience. 61
29869115 2018
200
A Unique Case of Renovascular Hypertension due to Fibromuscular Dysplasia in an Extra-renal Artery. 61
29709926 2018
201
The management of pediatric renovascular hypertension: a single center experience and review of the literature. 61
29397961 2018
202
[Analysis of structural features of gut microbiota in two-kidney-one-clip hypertensive rats based on high-throughput sequencing technology]. 61
30293377 2018
203
Altered expression of Aquaporin-2 in one-kidney, one-clip hypertension. 61
30009821 2018
204
Atrial secretion of ANP is suppressed in renovascular hypertension: shifting of ANP secretion from atria to the left ventricle. 61
29979625 2018
205
Differences in renal hemodynamics and renin secretion between patients with unifocal and multifocal fibromuscular dysplasia. 61
29889158 2018
206
Diagnosis and management of systemic hypertension due to renovascular and aortic stenosis in patients with Williams-Beuren syndrome. 61
30673043 2018
207
Unilateral renal artery stenosis presenting as acute flaccid paralysis: a rare presentation. 61
30171155 2018
208
Renovascular hypertension in small children-is it Takayasu arteritis or fibromuscular dysplasia? 61
29861130 2018
209
Should first blood pressure measurement be performed in the newborn? 61
29789210 2018
210
Orthotopic renal autotransplantation for young-onset and medical treatment-requiring complex renovascular hypertension. 61
30129810 2018
211
Long-Term Outcomes of Selective Renal Artery Embolization for Renal Arteriovenous Fistulae with Dilated Venous Sac. 61
29628300 2018
212
Direct Recording of Cardiac and Renal Sympathetic Nerve Activity Shows Differential Control in Renovascular Hypertension. 61
29686011 2018
213
Ccl2 deficiency protects against chronic renal injury in murine renovascular hypertension. 61
29872089 2018
214
Boldine Improves Kidney Damage in the Goldblatt 2K1C Model Avoiding the Increase in TGF-β. 61
29941815 2018
215
Neonatal renovascular hypertension. 61
29878627 2018
216
Interventions in children with renovascular hypertension: A 27-year retrospective single-center experience. 61
29635838 2018
217
Beneficial effect of combined spironolactone and quinapril treatment on thrombosis and hemostasis in 2K1C hypertensive rats. 61
29980144 2018
218
Renovascular hypertension associated with JAK2 V617F positive myeloproliferative neoplasms treated with angioplasty: 2 cases and literature review. 61
29656438 2018
219
Renovascular hypertension: endovascular therapy in complicated aortic Stanford type B dissection. 61
29850408 2018
220
Possible interesting link between Janus kinase 2 mutation and renovascular hypertension. 61
29656557 2018
221
Chronic intermittent hypoxia and renovascular hypertension: A case of one plus one equals one-half! 61
29377392 2018
222
Segmental arterial mediolysis presenting as spontaneous bilateral renal artery dissection. 61
29904497 2018
223
Correction to: Comments on Chavent et al.: Renovascular hypertension: results in adulthood of renal autotransplantation performed in children. 61
29404688 2018
224
Pediatric renovascular hypertension: Treatment outcome according to underlying disease. 61
29281158 2018
225
Renal resistive index for renovascular hypertension: In the quest of the Holy Grail. 61
29450962 2018
226
Quercetin decreases the activity of matrix metalloproteinase-2 and ameliorates vascular remodeling in renovascular hypertension. 61
29425960 2018
227
Renovascular hypertension increases serum TNF and CX3CL1 in experimental Trypanosoma cruzi infection. 61
29590257 2018
228
Transplant renal artery stenosis caused by the stretch of an artey branch: a case report and literature review. 61
29523086 2018
229
Enhanced angiotensin II induced sodium appetite in renovascular hypertensive rats. 61
29305157 2018
230
Carthamus tinctorius L. extract improves hemodynamic and vascular alterations in a rat model of renovascular hypertension through Ang II-AT1R-NADPH oxidase pathway. 61
29274384 2018
231
Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation. 61
29065722 2018
232
Direct renin inhibition is not enough to prevent reactive oxygen species generation and vascular dysfunction in renovascular hypertension. 61
29331564 2018
233
Opioid receptors mediate inotropic and depressor effects of apelin in rats with 2K1C-induced chronic renovascular hypertension. 61
28945940 2018
234
An infant case of renovascular hypertension in moyamoya disease treated by angioplasty. 61
30511550 2018
235
Takayasu's disease effects on the kidneys: current perspectives. 61
30147353 2018
236
Role of renin-angiotensin aldosterone system on short-term blood pressure variability in hypertensive patients. 61
29244537 2018
237
Renovascular Mistaken as Essential Hypertension due to Giant Hepatic Hydatid: A Rare Treatable Entity. 61
29731770 2018
238
Current Concepts in the Treatment of Renovascular Hypertension. 61
28985335 2018
239
Electroacupuncture Improves Baroreflex and γ-Aminobutyric Acid Type B Receptor-Mediated Responses in the Nucleus Tractus Solitarii of Hypertensive Rats. 61
30363902 2018
240
Morphological and functional renovascular changes as cause of resistant arterial hypertension - case report and literature review. 61
29940645 2018
241
A Newly Isolated Carboxymethyl-Glucan (CM-G) Restores Depressed Baroreflex Sensitivity in Renovascular Hypertensive Rats. 61
29875700 2018
242
Recommendations for ultrasonographic assessment of renal arteries. 61
30763019 2018
243
Borderline bilateral renal artery stenosis assessed with high-resolution angiography, intravascular ultrasound, and renal fractional flow reserve in a patient with renovascular hypertension. 61
29756199 2018
244
Arterial Stiffness in a Toddler with Neurofibromatosis Type 1 and Refractory Hypertension. 61
30515340 2018
245
Renin dependent hypertension caused by accessory renal arteries. 61
30410790 2018
246
Dynamics of Distribution of Capillaries with Matrix Metalloproteinase-2 and Its Tissue Inhibitor in Rat Brain during Development of Experimental Hypertension. 61
29308554 2018
247
Vaccarin alleviates hypertension and nephropathy in renovascular hypertensive rats. 61
29399101 2018
248
[Changes in spatial relationships between catecholamine- and nitroxidergic neurons in the nuclei of the caudal brain stem in the development of hypertension]. 61
29460906 2018
249
A rare case report of bilateral common and internal iliac arterial fibromuscular dysplasia: Coexisted dissection, aneurysm, and stenosis. 61
29390277 2017
250
Differential effects of renal denervation on arterial baroreceptor function in Goldblatt hypertension model. 61
28688830 2017
251
Heterodimerization of apelin and opioid receptors and cardiac inotropic and lusitropic effects of apelin in 2K1C hypertension: Role of pERK1/2 and PKC. 61
28987634 2017
252
ACR Appropriateness Criteria® Renovascular Hypertension. 61
29101991 2017
253
Maternal Renovascular Hypertensive Rats Treatment With Hydrogen Sulfide Increased the Methylation of AT1b Gene in Offspring. 61
28985312 2017
254
Unenhanced renal magnetic resonance angiography in patients with chronic kidney disease & suspected renovascular hypertension: Can it affect patient management? 61
29578191 2017
255
Selective embolization therapy for intrarenal artery stenosis causing renovascular hypertension: Efficacy and follow-up renal imaging. 61
28560752 2017
256
Secondary Hypertension: Discovering the Underlying Cause. 61
29094913 2017
257
[Masks of urogenital tuberculosis as the cause of diagnostic errors]. 61
29135152 2017
258
Comments on Chavent et al.: Renovascular hypertension: results in adulthood of renal autotransplantation performed in children. 61
28695307 2017
259
Renovascular hypertension: results in adulthood of renal autotransplantation performed in children. 61
28429121 2017
260
Effect of asiatic acid on the Ang II-AT1R-NADPH oxidase-NF-κB pathway in renovascular hypertensive rats. 61
28733880 2017
261
Renovascular hypertension: results in adulthood of renal autotransplantation performed in children-response to comments by Della Schiava and Lermusiaux. 61
28695308 2017
262
Oleuropein improves glucose tolerance and lipid profile in rats with simultaneous renovascular hypertension and type 2 diabetes. 61
28347166 2017
263
Effect of Euterpe oleracea Mart. Seeds Extract on Chronic Ischemic Renal Injury in Renovascular Hypertensive Rats. 61
28650699 2017
264
Intrarenal Angiotensin-Converting Enzyme: the Old and the New. 61
28929450 2017
265
Factors Associated With Need for Revascularisation in Non-coronary Arterial Occlusive Lesions Secondary to Takayasu's Arteritis. 61
28709561 2017
266
Frequency of Acccessory Renal Arteries Diagnosed by Computerized Tomography. 61
29114109 2017
267
Ultrasound imaging of renin-mediated hypertension. 61
28779201 2017
268
Revisiting angioplasty for renovascular hypertension. 61
28852488 2017
269
Transplantation of bone marrow-derived MSCs improves renal function and Na++K+-ATPase activity in rats with renovascular hypertension. 61
28374150 2017
270
The differential effects of low and high doses of apelin through opioid receptors on the blood pressure of rats with renovascular hypertension. 61
28275232 2017
271
Lotus Root Sign in the Renal Artery in Renovascular Hypertension. 61
28250287 2017
272
Intermittent claudication and severe renal artery stenosis are independently associated in hypertensive patients referred for renal arteriography. 61
28793000 2017
273
99mTc-MAG3: Image Wisely. 61
28212051 2017
274
Effects of peripherally and centrally applied ghrelin on the oxidative stress induced by renin angiotensin system in a rat model of renovascular hypertension. 61
28315847 2017
275
Renal denervation in a patient with unilateral ectopic kidney in the pelvis and refractory hypertension. 61
27240463 2017
276
[Hypertension during Takayasu's disease: An Algerian single center experience of 279 patients]. 61
28554696 2017
277
Sonographic evaluation of renovascular hypertension in the pediatric population: State-of-the-art. 61
28370243 2017
278
Pediatric Vascular Surgery Review with a 30-Year-Experience in a Tertiary Referral Center. 61
28690995 2017
279
Effects of Baicalin on Blood Pressure and Left Ventricular Remodeling in Rats with Renovascular Hypertension. 61
28622281 2017
280
Iron restriction in renovascular hypertension. 61
28250410 2017
281
Reply to 'Iron restriction in renovascular hypertension'. 61
28250413 2017
282
Fenofibrate Attenuates Hypertension in Goldblatt Hypertensive Rats: Role of 20-Hydroxyeicosatetraenoic Acid in the Nonclipped Kidney. 61
28641720 2017
283
Establishment and evaluation of a reversible two-kidney, one-clip renovascular hypertensive rat model. 61
28587402 2017
284
Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. 61
28449828 2017
285
Elevated urinary podocyte-derived extracellular microvesicles in renovascular hypertensive patients. 61
27190371 2017
286
Complex glomerular pathology of thrombotic microangiopathy and focal segmental glomerulosclerosis forms tumor-like mass in a renal transplant donor with severe renovascular hypertension. 61
28509120 2017
287
Nuclear Medicine in Pediatric Nephro-Urology: An Overview. 61
28417852 2017
288
Successful long-term effects of direct renin inhibitor aliskiren in a patient with atherosclerotic renovascular hypertension. 61
28509129 2017
289
Antihypertensive Effects of Hydroalcoholic Extract of Crataegus Azarolus Subspecies Aronia Fruit in Rats with Renovascular Hypertension: An Experimental Mechanistic Study. 61
28533575 2017
290
Renovascular hypertension in a patient with Takayasu arteritis. 61
27450162 2017
291
Pathophysiological differences between multifocal fibromuscular dysplasia and atherosclerotic renal artery stenosis. 61
28060190 2017
292
Renal Artery Stenosis: When to Revascularize in 2017. 61
28325353 2017
293
The activation of the kynurenine pathway in a rat model with renovascular hypertension. 61
28165296 2017
294
TRPM8 downregulation by angiotensin II in vascular smooth muscle cells is involved in hypertension. 61
28138709 2017
295
Increased Expression of Macrophage Migration Inhibitory Factor in the Nucleus of the Solitary Tract Attenuates Renovascular Hypertension in Rats. 61
28158469 2017
296
Fibromuscular dysplasia in an adult male as a cause of renal artery stenosis and secondary hypertension treated with renal artery stenting. 61
29622959 2017
297
A severe pulmonary complication in a patient with COL4A1-related disorder: A case report. 61
28017902 2017
298
Outcomes of percutaneous transluminal angioplasty for pediatric renovascular hypertension. 61
27634559 2017
299
Cesarean Section Revealing an Unsuspected Renal Angiomyolipoma in a Woman with Severe Hypertension During Pregnancy: A Case Report. 61
30230799 2017
300
New Insights Into Pathophysiology, Diagnosis, and Treatment of Renovascular Hypertension. 61
28270639 2017
301
Non-invasive imaging cannot replace formal angiography in the diagnosis of renovascular hypertension. 61
27747454 2017
302
Running Exercise and Angiotensin II Type I Receptor Blocker Telmisartan Are Equally Effective in Preventing Angiotensin II-Mediated Vulnerable Atherosclerotic Lesions. 61
27246357 2017
303
Reconstruction for renal artery aneurysms using the tailoring technique. 61
27687328 2017
304
Duplex ultrasound for identifying renal artery stenosis: direct criteria re-evaluated. 61
27069093 2017
305
Elevated ischaemia-associated lysyl oxidase activity in delayed graft failure 6-12 months after renal transplantation. 61
28024102 2017
306
Snakes and Hypertension. 61
27861171 2017
307
Renal Branch Artery Stenosis: A Diagnostic Challenge? A Case Report With Review of the Literature. 61
27369816 2017
308
Revascularization in a 17-Year-Old Girl with Neurofibromatosis and Severe Hypertension Caused by Renal Artery Stenosis. 61
28265213 2017
309
Supersized Atheroma Causing Acquired Coarctation of Aorta Leading to Heart Failure. 61
28203578 2017
310
Cardiovascular phenotype in Smad3 deficient mice with renovascular hypertension. 61
29073282 2017
311
Takayasu arteritis presenting with malignant hypertension; a rare manifestation of a rare disease: a case report and review of the literature. 61
27216226 2017
312
Long-Term Outcomes of Pediatric Renovascular Hypertension. 61
28950261 2017
313
Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosis. 61
28306749 2017
314
Increased Apoptosis in the Paraventricular Nucleus Mediated by AT1R/Ras/ERK1/2 Signaling Results in Sympathetic Hyperactivity and Renovascular Hypertension in Rats after Kidney Injury. 61
28210225 2017
315
Roles of HDAC2 and HDAC8 in Cardiac Remodeling in Renovascular Hypertensive Rats and the Effects of Valproic Acid Sodium. 61
27673327 2017
316
Renal sympathetic denervation attenuates hypertension and vascular remodeling in renovascular hypertensive rats. 61
27742806 2017
317
Cooperative Oxygen Sensing by the Kidney and Carotid Body in Blood Pressure Control. 61
29046642 2017
318
Alibertia edulis (L.C. Rich.) A.C. Rich - A potent diuretic arising from Brazilian indigenous species. 61
27988400 2017
319
Increased Dietary Salt Changes Baroreceptor Sensitivity and Intrarenal Renin-Angiotensin System in Goldblatt Hypertension. 61
27629265 2017
320
Short-term treatment with nitrate is not sufficient to induce in vivo antithrombotic effects in rats and mice. 61
27743016 2017
321
Hydrogen Sulfide Improves Myocardial Remodeling via Downregulated Angiotensin Ⅱ/AT1R Pathway in Renovascular Hypertensive Rats. 61
27600580 2017
322
Renal Artery Stenosis in Patients with Resistant Hypertension: Stent It or Not? 61
28150134 2017
323
Renal Arterial Disease and Hypertension. 61
27884236 2017
324
Kidney injury secondary to endovascular treatment of renal artery stenosis. 61
28594810 2017
325
Treatment of severe hypertension in a 14-year-old child: Successful blood pressure control with additive administration of captopril, an angiotensin-converting enzyme inhibitor, in a patient with bilateral renovascular hypertension. 61
28621587 2017
326
Roles of Nitric Oxide and Prostaglandins in the Sustained Antihypertensive Effects of Acanthospermum hispidum DC. on Ovariectomized Rats with Renovascular Hypertension. 61
29234376 2017
327
Obstetrical management of patients with extra-anatomic vascular bypass grafts due to Takayasu arteritis. 61
27718287 2016
328
Animal models for the study of primary and secondary hypertension in humans. 61
28105333 2016
329
Large retroperitoneal immature teratoma leading to renovascular hypertension. 61
28008730 2016
330
Novel insights into renovascular hypertension and cardio-renal protection by iron restriction. 61
27604341 2016
331
Behçet's Disease Presenting as Renovascular Hypertension Treated Successfully With Percutaneous Angioplasty. 61
27916225 2016
332
Chrysanthemum morifolium extract improves hypertension-induced cardiac hypertrophy in rats by reduction of blood pressure and inhibition of myocardial hypoxia inducible factor-1alpha expression. 61
27268080 2016
333
Harry Goldblatt (1891-1977): Pathologist and Medical Researcher. 61
29283537 2016
334
Attenuation of hypertension and renal damage in renovascular hypertensive rats by iron restriction. 61
27439494 2016
335
Low-Energy Shockwave Therapy Improves Ischemic Kidney Microcirculation. 61
27297945 2016
336
Carotid sinus denervation ameliorates renovascular hypertension in adult Wistar rats. 61
27510951 2016
337
Idiopathic midaortic syndrome with malignant hypertension in 3-year-old boy. 61
28018454 2016
338
Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension. 61
27602985 2016
339
Exercise training attenuates renovascular hypertension partly via RAS- ROS- glutamate pathway in the hypothalamic paraventricular nucleus. 61
27881877 2016
340
Aliskiren and l-arginine treatments restore depressed baroreflex sensitivity and decrease oxidative stress in renovascular hypertension rats. 61
27383506 2016
341
Decreased immunoreactivity of visfatin in the pancreas and liver of rats with renovascular hypertension. 61
28078856 2016
342
Clinical, angiographic profile and percutaneous endovascular management of Takayasu's arteritis - A single centre experience. 61
27420344 2016
343
Involvement of bradykinin B2 and muscarinic receptors in the prolonged diuretic and antihypertensive properties of Echinodorus grandiflorus (Cham. & Schltdl.) Micheli. 61
26776663 2016
344
Transplant renal artery stenosis: The impact of endovascular management and their outcomes. 61
27843211 2016
345
Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension. 61
26824982 2016
346
Management of Renovascular Hypertension. 61
27641455 2016
347
Tempol improves xanthine oxidoreductase-mediated vascular responses to nitrite in experimental renovascular hypertension. 61
27078869 2016
348
Development of renal atrophy in murine 2 kidney 1 clip hypertension is strain independent. 61
27473991 2016
349
Hypercholesterolemia Impairs Nonstenotic Kidney Outcomes After Reversal of Experimental Renovascular Hypertension. 61
26739189 2016
350
Paraventricular Nucleus Infusion of Epigallocatechin-3-O-Gallate Improves Renovascular Hypertension. 61
26162770 2016
351
Chronic intermittent hypobaric hypoxia antagonizes renal vascular hypertension by enhancement of vasorelaxation via activating BKCa. 61
27216772 2016
352
[Nephrectomies in poor or non-functioning kidneys. Is it the right thing to do?] 61
28393507 2016
353
Renal hemodynamics and renin-angiotensin system activity in humans with multifocal renal artery fibromuscular dysplasia. 61
27032075 2016
354
Prior renovascular hypertension does not predispose to atherosclerosis in mice. 61
27100924 2016
355
Atherosclerotic Renal Artery Stenosis and Hypertension: Pragmatism, Pitfalls, and Perspectives. 61
26522797 2016
356
Body MR angiography in children: how we do it. 61
27229494 2016
357
Infantile Renovascular Hypertension with Failure to Thrive. 61
26965798 2016
358
Restoration of Mitochondrial Cardiolipin Attenuates Cardiac Damage in Swine Renovascular Hypertension. 61
27247333 2016
359
Remedial operations for failed endovascular therapy of 32 renal artery stenoses in 24 children. 61
26628283 2016
360
Interlobular Arteries From 2-Kidney, 1-Clip Goldblatt Hypertensive Rats' Exhibit-Impaired Vasodilator Response to Epoxyeicosatrienoic Acids. 61
27140711 2016
361
Imperatorin derivative OW1 inhibits the upregulation of TGF-β and MMP-2 in renovascular hypertension-induced cardiac remodeling. 61
27168797 2016
362
Corrigendum. 61
27188518 2016
363
[Takayasu arteritis]. 61
26827273 2016
364
Therapeutic evaluation of rutin in two-kidney one-clip model of renovascular hypertension in rat. 61
26920631 2016
365
Apigenin ameliorates hypertension-induced cardiac hypertrophy and down-regulates cardiac hypoxia inducible factor-lα in rats. 61
26987380 2016
366
Simultaneous Open Surgical Treatment of Aortic Coral Reef and Leriche Syndrome: Case Report and Literature Review. 61
26806247 2016
367
Detection of Segmental Renal Ischemia by Diffusion-Weighted Magnetic Resonance Imaging: Clinical Utility for Diagnosis of Renovascular Hypertension. 61
26360321 2016
368
Atherosclerotic renal artery stenosis in the post-CORAL era part 1: the renal penumbra concept and next-generation functional diagnostic imaging. 61
26944791 2016
369
Takayasu arteritis associated with severe renovascular hypertension. 61
26997400 2016
370
Resveratrol improves vasoprotective effects of captopril on aortic remodeling and fibrosis triggered by renovascular hypertension. 61
26764145 2016
371
Constipation, renovascular hypertension, and posterior reversible encephalopathy syndrome (PRES). 61
26319009 2016
372
Blockade of CCR2 reduces macrophage influx and development of chronic renal damage in murine renovascular hypertension. 61
26661648 2016
373
Impact of Small Renal Ischemia in Hypertension Development: Renovascular Hypertension Caused by Small Branch Artery Stenosis. 61
26293888 2016
374
Current management of renal artery stenosis. 61
26730463 2016
375
Percutaneous Transluminal Angioplasty Improved Posterior Reversible Encephalopathy Syndrome due to Renovascular Hypertension. 61
26646732 2016
376
Selective stent placement versus balloon angioplasty for renovascular hypertension caused by Takayasu arteritis: Two-year results. 61
26730842 2016
377
Regular exercise alleviates renovascular hypertension-induced cardiac/endothelial dysfunction and oxidative injury in rats. 61
27010894 2016
378
Morphological Identification of TRPC7 in Cardiomyocytes From Normal and Renovascular Hypertensive Rats. 61
26371949 2016
379
Surgical Treatment of Abdominal Aortic Aneurysm with Congenital Solitary Pelvic Kidney and Superior Mesenteric Artery Stenosis. 61
27738466 2016
380
To intervene or not? A man with multidrug-resistant hypertension, endovascular abdominal aneurysm repair, bilateral renal artery stenosis and end-stage renal disease salvaged with renal artery stenting. 61
26581234 2016
381
[Hypertension due to fibromuscular dysplasia: look for additional disease sites]. 61
27827286 2016
382
A case of treatable hypertension: fibromuscular dysplasia of renal arteries. 61
26724918 2016
383
Associated extrarenal vascular diseases may complicate the treatment and outcome of renovascular hypertension. 61
26437121 2016
384
Antagonism of Endothelin (ETA and ETB) Receptors During Renovascular Hypertension-Induced Vascular Dementia Improves Cognition. 61
27189349 2016
385
Autophagy Portends the Level of Cardiac Hypertrophy in Experimental Hypertensive Swine Model. 61
25904651 2016
386
Impaired Neovascularization and Reduced Capillary Supply in the Malignant vs. Non-malignant Course of Experimental Renovascular Hypertension. 61
27625610 2016
387
Cardiovascular manifestations of renovascular hypertension in diabetic mice. 61
26925344 2016
388
Estrogen receptor agonists alleviate cardiac and renal oxidative injury in rats with renovascular hypertension. 61
27399230 2016
389
Renovascular hypertension: Effects of mesenchymal stem cells in the contralateral hypertensive kidney in rats. 61
27649588 2016
390
Anti-hypertensive Effects of Diminazene Aceturate: An Angiotensin- Converting Enzyme 2 Activator in Rats. 61
26458404 2016
391
Topochemistry of Internuclear and Intranuclear Interneurons of the Vasomotor Area in the Medulla Oblongata of Hypertensive Rats. 61
26746841 2016
392
Duplex derived intrarenal resistance index correlates with invasive pressure gradient measurements in detecting relevant unilateral renal artery stenosis. 61
27058805 2016
393
Plasma Renin Activity Predicts the Improvement in Resistant Hypertension after Percutaneous Transluminal Renal Artery Angioplasty. 61
27904103 2016
394
Hemodynamic and neural responses to renal denervation of the nerve to the clipped kidney by cryoablation in two-kidney, one-clip hypertensive rats. 61
26582638 2016
395
Role of xanthine oxidoreductase in the anti-thrombotic effects of nitrite in rats in vivo. 61
26374946 2016
396
Ghrelin-immunoreactive cells in the gastrointestinal tract of hypertensive rats. 61
27966210 2016
397
Aortic Intimal Sarcoma Contributes to Atherosclerotic Renovascular Hypertension: An Autopsy Case Report and Review of the Literature. 61
27041160 2016
398
Mesenchymal stem cells and chronic renal artery stenosis. 61
26538439 2016
399
Selective Serotonin-norepinephrine Re-uptake Inhibition Limits Renovas-cular-hypertension Induced Cognitive Impairment, Endothelial Dysfunction, and Oxidative Stress Injury. 61
26915517 2016
400
Improvement of left ventricular filling and pulmonary artery pressure following unilateral renal artery total occlusion stenting in a patient with recurrent congestive heart failure complicated by renovascular hypertension and renal failure. 61
27774260 2015
401
Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension. 61
26343345 2015
402
Brain Stem Hemorrhage in a 2-Year-10-Month-Old Child with Renovascular Hypertension Related to Fibromuscular Dysplasia. 61
27122924 2015
403
[Secondary hypertension]. 61
26619670 2015
404
Successful cutting balloon angioplasty in a child with resistant renal artery stenosis. 61
26564026 2015
405
Splenorenal graft: A safe and effective treatment for renovascular hypertension. 61
26664214 2015
406
Influence of renovascular hypertension on the distribution of vasoactive intestinal peptide in the stomach and heart of rats. 61
25990439 2015
407
Angiotensin-(1-7) enhances the effects of angiotensin II on the cardiac sympathetic afferent reflex and sympathetic activity in rostral ventrolateral medulla in renovascular hypertensive rats. 61
26428223 2015
408
Mycotic Saccular Abdominal Aortic Aneurysm in an Infant after Cardiac Catheterization: A Case Report. 61
26115611 2015
409
Anti-platelet and anti-hypertension medication use in patients with fibromuscular dysplasia: Results from the United States Registry for Fibromuscular Dysplasia. 61
25964292 2015
410
Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats. 61
26304700 2015
411
How to measure renal artery stenosis--a retrospective comparison of morphological measurement approaches in relation to hemodynamic significance. 61
26459634 2015
412
The Nuclear Factor kappaB Inhibitor Pyrrolidine Dithiocarbamate Prevents Cardiac Remodelling and Matrix Metalloproteinase-2 Up-Regulation in Renovascular Hypertension. 61
25816715 2015
413
Gastric S-nitrosothiol formation drives the antihypertensive effects of oral sodium nitrite and nitrate in a rat model of renovascular hypertension. 61
26159506 2015
414
Aldosterone Contributes to Sympathoexcitation in Renovascular Hypertension. 61
25628418 2015
415
Renal Artery Stenosis: Optimal Therapy and Indications for Revascularization. 61
26238738 2015
416
Renovascular hypertension: a case with atypical neurological signs. 61
26351310 2015
417
Mas receptor overexpression increased Ang-(1-7) relaxation response in renovascular hypertensive rat carotid. 61
26256416 2015
418
Laparoscopic Nephrectomy with Autotransplantation: Safety, Efficacy and Long-Term Durability. 61
25801764 2015
419
Management of the renovascular disease in children with Takayasu arteritis. 61
25975436 2015
420
Inferior mesenteric to renal artery transposition for revascularization of a solitary functioning kidney. 61
26072720 2015
421
Cardiac metabolic alterations in hypertensive obese pigs. 61
26077566 2015
422
Renal-limited necrotizing granulomatous vasculitis in a pediatric patient. 61
26315202 2015
423
Secondary Hypertension in Pregnancy. 61
26068655 2015
424
Combined Aliskiren and L-arginine treatment reverses renovascular hypertension in an animal model. 61
25740291 2015
425
Attenuation of renovascular hypertension by cyclooxygenase-2 inhibitor partly through ANP release. 61
25846103 2015
426
Peptides-Derived from Thai Rice Bran Improves Endothelial Function in 2K-1C Renovascular Hypertensive Rats. 61
26184305 2015
427
The results of treatment in renal artery stenosis due to Takayasu disease: comparison between surgery, angioplasty, and stenting. A monocentrique retrospective study. 61
26712071 2015
428
Long-segment thoracoabdominal aortic coarctation in a child with Down syndrome. 61
31724602 2015
429
[Renal hypertension--the role of the kidneys in blood pressure regulation and the kidneys as end organ]. 61
26098186 2015
430
Retrograde Renal Ablation via the Renal Vein as a New Treatment Option for Renovascular Hypertension. 61
25812711 2015
431
[Laboratory Medicine Learned Through Research on the Pathogenesis of Hypertension]. 61
26524901 2015
432
Angioplasty for renovascular hypertension in 78 children. 61
25527520 2015
433
Mild Renal Artery Stenosis Can Induce Renovascular Hypertension and is Associated with Elevated Renal Vein Renin Secretion. 61
24943669 2015
434
Angioplasty for recurrent renal artery stenosis in flare-up of Hashimoto's thyroiditis. 61
25868954 2015
435
Mechanisms of renal sympathetic activation in renovascular hypertension. 61
25639235 2015
436
Effects of mesenchymal stem cells in renovascular hypertension. 61
25605443 2015
437
Melatonin receptor and KATP channel modulation in experimental vascular dementia. 61
25659733 2015
438
Attenuated muscle metaboreflex-induced pressor response during postexercise muscle ischemia in renovascular hypertension. 61
25632024 2015
439
Quantitative evaluation of CART-containing cells in urinary bladder of rats with renovascular hypertension. 61
26150151 2015
440
The crosstalk between the kidney and the central nervous system: the role of renal nerves in blood pressure regulation. 61
25599970 2015
441
Effect of naringin on hemodynamic changes and left ventricular function in renal artery occluded renovascular hypertension in rats. 61
25883516 2015
442
Treatment of atherosclerotic renovascular hypertension: review of observational studies and a meta-analysis of randomized clinical trials. 61
24744282 2015
443
Coronary artery stenosis: a new risk factor for chronic kidney injury? 61
25826540 2015
444
Evaluation of CART-, glucagon-, and insulin-immunoreactive cells in the pancreas of an experimental rat model of unilateral renal artery stenosis. 61
25229552 2015
445
Outcome of takayasu arteritis with inactive disease at diagnosis: the extent of vascular involvement as a predictor of activation. 61
25512482 2015
446
Biomarkers of kidney injury and klotho in patients with atherosclerotic renovascular disease. 61
25542906 2015
447
Renovascular hypertension 2014: what have we learned from CORAL? 61
25211054 2015
448
Successful percutaneous transluminal angioplasty for the treatment of renovascular hypertension with an atrophic kidney. 61
24384893 2015
449
Morphologic changes of cerebral veins in hypertensive rats: venous collagenosis is associated with hypertension. 61
25534370 2015
450
[Ischemic renal disease and renal artery stenosis]. 61
25608998 2015
451
Norepinephrinergic and nitroxidergic neurons of vasomotor nuclei in hypertensive rats. 61
25778663 2015
452
Renal artery stenosis. 61
25439331 2015
453
Clinical efficacy of percutaneous transluminal renal artery stenting for the treatment of renovascular hypertension associated with Takayasu arteritis. 61
25725281 2015
454
Nephron-sparing surgery for treatment of reninoma: a rare renin secreting tumor causing secondary hypertension. 61
25928524 2015
455
Diagnostic and medical strategy for renovascular hypertension: report from a monocentric pediatric cohort. 61
24953377 2015
456
Intrarenal Delivery of Mesenchymal Stem Cells and Endothelial Progenitor Cells Attenuates Hypertensive Cardiomyopathy in Experimental Renovascular Hypertension. 61
25420012 2015
457
Voluntary Exercise Stabilizes Established Angiotensin II-Dependent Atherosclerosis in Mice through Systemic Anti-Inflammatory Effects. 61
26600018 2015
458
[Renovascular hypertension]. 61
27162297 2015
459
Renal perfusional cortex volume for arterial input function measured by semiautomatic segmentation technique using MDCT angiographic data with 0.5-mm collimation. 61
25539243 2015
460
Sildenafil Improves Vascular Endothelial Structure and Function in Renovascular Hypertension. 61
26059106 2015
461
Ultrastructural pathological features of unilateral renal artery stenosis in the rats. 61
26191171 2015
462
Clinical outcome of renal artery stenting for hypertension and chronic kidney disease up to 12 months in the J-RAS Study – prospective, single-arm, multicenter clinical study. 61
25476409 2015
463
Cardiovascular news 2013/2014. 61
25439172 2015
464
[Clinical and angiographic manifestations inpatients without previous diagnosis of Takayasu´s arteritis]. 61
26020667 2015
465
Hydrogen sulfide improves the endothelial dysfunction in renovascular hypertensive rats. 61
25804097 2015
466
Intra-renal delivery of mesenchymal stem cells attenuates myocardial injury after reversal of hypertension in porcine renovascular disease. 61
25599803 2015
467
Preliminary assessment of interand intraobserver reproducibility, and normative values of renal mean transit time (MTT) and parenchymal transit time (PTT) for 99mTc-etylenodicysteine. 61
25633514 2015
468
Two pools of interneurons in the bulbar region of the cardiovascular center of rats. 61
26335965 2015
469
Combined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension. 61
25493385 2015
470
Iliac artery obliteration as a cause of renovascular hypertension in kidney graft recipients: A difficult and uncommon diagnosis. 61
26306960 2015
471
Hemodynamic assessment in a child with renovascular hypertension using time-resolved three-dimensional cine phase-contrast MRI. 61
24615925 2015
472
Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series. 61
25434739 2014
473
Renovascular hypertension: to stent or not to stent? 61
25245390 2014
474
An atypical clinical presentation of renovascular hypertension. 61
25300660 2014
475
Secondary hypertension, issues in diagnosis and treatment. 61
25439532 2014
476
SCAI expert consensus statement for renal artery stenting appropriate use. 61
25138644 2014
477
Secondary hypertension: renovascular hypertension. 61
25492839 2014
478
Duplex ultrasound findings before and after surgery in children and adolescents with renovascular hypertension. 61
25308948 2014
479
Mechanisms of phytoestrogen biochanin A-induced vasorelaxation in renovascular hypertensive rats. 61
26885474 2014
480
An exceptional case of renal artery restenosis in a patient with polycythaemia vera. 61
24991947 2014
481
[Renal injury in Takayasu's arteritis]. 61
25440941 2014
482
[Difficulty in diagnosis of primary hyperaldosteronism as the cause of resistant hypertension and severe hypokalemia--case report]. 61
25546991 2014
483
Arterial stiffness in atherosclerotic renovascular hypertension. 61
25275250 2014
484
Swimming training promotes cardiac remodeling and alters the expression of mRNA and protein levels involved in calcium handling in hypertensive rats. 61
25283082 2014
485
Aortic bypass and orthotopic right renal autotransplantation for midaortic syndrome: a case report. 61
25370165 2014
486
[Early diagnosis of Takayasu's disease (clinical case report)]. 61
25831704 2014
487
Use of a pulsatile perfusion pump for renal autotransplantation in a patient undergoing thoracoabdominal bypass for malignant hypertension secondary to Takayasu arteritis. 61
24698771 2014
488
Dynamics of cocaine- and amphetamine-regulated transcript containing cell changes in the adrenal glands of two kidney, one clip rats. 61
24939825 2014
489
Increased expression of angiotensin II type 2 receptors in the solitary-vagal complex blunts renovascular hypertension. 61
24958505 2014
490
Cardiac sympathetic afferent reflex response to intermedin microinjection into paraventricular nucleus is mediated by nitric oxide and γ-amino butyric acid in hypertensive rats. 61
24872434 2014
491
Quantitative and qualitative evaluation of CART-containing cells in adrenal glands of male rats with hypertension. 61
25151991 2014
492
Inhibition of phosphodiesterase 5 restores endothelial function in renovascular hypertension. 61
25223948 2014
493
Alterations of rat stomach endocrine cells under renovascular hypertension. 61
25323756 2014
494
Blockade of renin-angiotensin system prevents micturition dysfunction in renovascular hypertensive rats. 61
24881522 2014
495
Chronic infusion of lisinopril into hypothalamic paraventricular nucleus modulates cytokines and attenuates oxidative stress in rostral ventrolateral medulla in hypertension. 61
24937322 2014
496
Minilaparoscopic-assisted laparoendoscopic single-site bilateral nephrectomies in postrenal transplant recipient: case report. 61
25242793 2014
497
(99m)Tc Diethylenetriaminepentacetic Acid Angiotension-coverting Enzyme Inhibitor Renography as Screening Test for Renovascular Hypertension in Unilateral Small Kidney: A Prospective Study. 61
25538486 2014
498
Antihypertensive and vascular remodelling effects of the imperatorin derivative OW1 in renovascular hypertension rats. 61
24798462 2014
499
Renal sonography with Doppler - not shown to be adequate as a screening tool for renovascular hypertension. 61
24728473 2014
500
β1-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophy. 61
24933619 2014
501
Reply to Drs. Brown and Karmazyn regarding the adequacy of renal sonography with Doppler in pediatric renovascular hypertension. 61
24728474 2014
502
Management of renal artery stenosis: What does the experimental evidence tell us? 61
25228964 2014
503
Solitary kidney with renal artery aneurysm repaired by ex vivo reconstruction. 61
24923285 2014
504
Middle aortic coarctation. 61
24361384 2014
505
Valsartan regulates myocardial autophagy and mitochondrial turnover in experimental hypertension. 61
24752430 2014
506
Revealing the role of the autonomic nervous system in the development and maintenance of Goldblatt hypertension in rats. 61
24560525 2014
507
Sympathoactivation and rho-kinase-dependent baroreflex function in experimental renovascular hypertension with reduced kidney mass. 61
24946879 2014
508
Extrarenal atherosclerotic disease blunts renal recovery in patients with renovascular hypertension. 61
24625655 2014
509
Venthamarai chooranam, a polyherbal Siddha medicine, alleviates hypertension via AT₁R and eNOS signaling pathway in 2K1C hypertensive rats. 61
24719376 2014
510
Natriuretic peptides buffer renin-dependent hypertension. 61
24717731 2014
511
Interventional radiologic techniques for screening, diagnosis and treatment of patients with renal artery stenosis. 61
24740274 2014
512
[Aneurysmal rupture complicating aortitis: a case report]. 61
24637031 2014
513
Early and long-term results after reconstructive surgery in 42 children and two young adults with renovascular hypertension due to fibromuscular dysplasia and middle aortic syndrome. 61
24583096 2014
514
[Diagnosis and treatment of patients with secondary arterial hypertension of adrenal and renal genesis]. 61
25211918 2014
515
Angioplasty for pediatric renovascular hypertension: a 13-year experience. 61
24675165 2014
516
Oxidative stress and endothelial dysfunction: clinical evidence and therapeutic implications. 61
24373981 2014
517
Endovascular treatment of renal artery stenosis improves contralateral renal hypertrophy with nephrotic syndrome. 61
28509242 2014
518
Renovascular hypertension after laparoscopic partial nephrectomy. 61
24508453 2014
519
Radionuclides in nephrourology, Part 2: pitfalls and diagnostic applications. 61
24591488 2014
520
Salusin-β in rostral ventrolateral medulla increases sympathetic outflow and blood pressure via superoxide anions in hypertensive rats. 61
24621806 2014
521
Endovascular management of a traumatic renal-caval arteriovenous fistula in a pediatric patient. 61
24360940 2014
522
Aortic stent and renal autotransplantation for the management of renovascular hypertension with Takayasu's arteritis: report of a case. 61
23512530 2014
523
Interventions for pediatric renovascular hypertension. 61
24522941 2014
524
[Occlusion of Peripheral Bypass - Changing of an Institutional Paradigm]. 61
27866403 2014
525
Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice. 61
24708836 2014
526
Findings of cardiac magnetic resonance imaging in asymptomatic myocardial ischemic disease in Takayasu arteritis. 61
24423899 2014
527
Cardiac function in renovascular hypertensive patients with and without renal dysfunction. 61
24162729 2014
528
Oxidative stress, the capo of endothelial dysfunction in chronic renovascular hypertension. 61
26877943 2014
529
Al18F-NODA-butyric acid: biological evaluation of a new PET renal radiotracer. 61
24533986 2014
530
Blood pressure response to renal artery stenting in 901 patients from five prospective multicenter FDA-approved trials. 61
24307609 2014
531
Clinical problems in renovascular disease and the role of nuclear medicine. 61
24484748 2014
532
Superoxide anions involved in sympathoexcitation and pressor effects of salusin-β in paraventricular nucleus in hypertensive rats. 61
24304512 2014
533
Treatment of hypertension in patients with renal artery stenosis due to fibromuscular dysplasia of the renal arteries. 61
24649423 2014
534
Sildenafil ameliorates oxidative stress and DNA damage in the stenotic kidneys in mice with renovascular hypertension. 61
24502628 2014
535
Intermedin in paraventricular nucleus attenuates sympathetic activity and blood pressure via nitric oxide in hypertensive rats. 61
24218431 2014
536
Non-invasive renal artery embolization for renal dysplasia accompanied by hypertension. 61
24548196 2014
537
Surgical revasculization for pediatric renovascular hypertension caused by fibromuscular dysplasia. 61
24719664 2014
538
Fibromuscular dysplasia presenting with asymptomatic bilateral renal infarctions. 61
23292597 2014
539
Optimal management of renal artery fibromuscular dysplasia. 61
25114536 2014
540
Retroperitoneal fibrosis. Exceptional cause of renal artery thrombosis with secondary hypertension. A case from University Mohamed V, CheikhZaid Hospital, Rabat, March 2013. 61
30546777 2014
541
Pregnancy and delivery in women with renovascular hypertension due to multiple intrarenal microaneurysms: a report of two cases. 61
25318796 2014
542
Neuroprotective effect of chondroitinase ABC on primary and secondary brain injury after stroke in hypertensive rats. 61
24326094 2014
543
Renovascular hypertension treated by renal artery embolization. 61
24339318 2014
544
Renovascular hypertension: a report of 21 cases. 61
24434389 2014
545
Primary renal artery choriocarcinoma causing secondary renovascular hypertension. 61
25437675 2014
546
Effects of Short-term Renovascular Hypertension and Type 2 Diabetes on Cardiac Functions in Rats. 61
24453394 2014
547
Mitochondrial targeted peptides attenuate residual myocardial damage after reversal of experimental renovascular hypertension. 61
24048008 2014
548
Reninoma: the importance of renal vein renin ratios for lateralisation and diagnosis. 61
24401674 2014
549
Aqueous extract of dioscorea opposita thunb. normalizes the hypertension in 2K1C hypertensive rats. 61
24447776 2014
550
Role of renal nerves in the treatment of renovascular hypertensive rats with L-arginine. 61
25349722 2014
551
Myocardial perfusion imaging in Takayasu arteritis. 61
24128776 2013
552
[Y-graft replacement with left renal artery reconstruction for acute aortic dissection type B]. 61
24322356 2013
553
Clinical management of renovascular hypertension: practical recommendations from the Italian Society of Hypertension (SIIA). 61
24046002 2013
554
Olmesartan medoxomil reverses left ventricle hypertrophy and reduces inflammatory cytokine IL-6 in the renovascular hypertensive rats. 61
24379062 2013
555
Paraventricular nucleus control of blood pressure in two-kidney, one-clip rats: effects of exercise training and resting blood pressure. 61
24089375 2013
556
Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension. 61
23806385 2013
557
[Current management of renal artery stenosis]. 61
24217529 2013
558
Takayasu's arteritis: oral complications and dental guidelines. 61
22901643 2013
559
Long term results of endovascular treatment in renal arterial stenosis from Takayasu arteritis: angioplasty versus stent placement. 61
23910995 2013
560
Effects of telmisartan and linagliptin when used in combination on blood pressure and oxidative stress in rats with 2-kidney-1-clip hypertension. 61
24077249 2013
561
Analysis of the sensitivity and specificity of noninvasive imaging tests for the diagnosis of renal artery stenosis. 61
24061685 2013
562
Renovascular hypertension associated with pseudoaneurysm following blunt trauma. 61
23518197 2013
563
Renal angioplasty for atherosclerotic renal artery stenosis: Cardiologist's perspective. 61
24346387 2013
564
Images in vascular medicine. A challenging case of renovascular hypertension. 61
23939017 2013
565
Hyponatremic-hypertensive syndrome: think of unilateral renal artery stenosis. 61
23152163 2013
566
Takayasu's arteritis and its role in causing renal artery stenosis. 61
23462245 2013
567
Non-enhanced MR angiography of renal arteries: comparison with contrast-enhanced MR angiography. 61
23550187 2013
568
Hypertension in women. 61
23978544 2013
569
Redox signaling is an early event in the pathogenesis of renovascular hypertension. 61
24025423 2013
570
Renovascular hypertension: is there still a role for stent revascularization? 61
23917028 2013
571
Sex-specific effects of heme oxygenase-2 deficiency on renovascular hypertension. 61
23721883 2013
572
Non-invasive assessment of cardiac function in a mouse model of renovascular hypertension. 61
23676847 2013
573
Multiple vascular variations at the vicinity of the left kidney. 61
23649479 2013
574
Reducing oxidative stress in the rostral ventrolateral medulla in renovascular hypertension by peripheral administration of losartan: how and where? 61
23747953 2013
575
Response to "Reducing oxidative stress in the rostral ventrolateral medulla in renovascular hypertension by peripheral administration of losartan: how and where?". 61
23824761 2013
576
Neurofibromas of the bladder in a child with neurofibromatosis type 1 causing chronic renal disease. 61
23815393 2013
577
[Clinical characteristics and imaging evaluation in children with renovascular hypertension]. 61
24225296 2013
578
Co-existence of renovascular hypertension, polyarteritis nodosa, antiphospholipid syndrome and methylenetetrahydrofolate reductase mutation. 61
23910811 2013
579
Renovascular hypertension leads to DNA damage and apoptosis in bone marrow cells. 61
23786322 2013
580
How to distinguish between inconsistencies in CTA results and DSA findings: interobserver variability cannot be ignored. 61
23338955 2013
581
Clinical analysis of hypertension in children: an urban Indian study. 61
23816747 2013
582
Losartan reduces oxidative stress within the rostral ventrolateral medulla of rats with renovascular hypertension. 61
23485486 2013
583
Successfully treated bilateral renal artery stenosis in a patient with coronary artery disease. 61
23737568 2013
584
Outcomes of endovascular interventions for salvage of renal transplant allografts. 61
23406713 2013
585
Salusin-β in paraventricular nucleus increases blood pressure and sympathetic outflow via vasopressin in hypertensive rats. 61
23400761 2013
586
Interactions between the sympathetic nervous system and angiotensin system in renovascular hypertension. 61
23971694 2013
587
Renovascular hypertension in an 8-year-old girl. 61
23645701 2013
588
Autotransplantation for renovascular hypertension in children with solitary functioning kidney. 61
23034578 2013
589
Beneficial effects of tibolone on blood pressure and liver redox status in ovariectomized rats with renovascular hypertension. 61
23089337 2013
590
Renal artery stenting: indications, techniques, and devices. 61
23492602 2013
591
Optimal medical management in patients with renovascular hypertension. 61
23494905 2013
592
The role of CT angiography in the evaluation of pediatric renovascular hypertension. 61
23208533 2013
593
Distribution of cocaine and amphetamine regulated transcript in ureters and urinary bladder of hypertensive rats. 61
23830391 2013
594
Pregnancy loss and later risk of atherosclerotic disease. 61
23536362 2013
595
Angiotensin-(1-7) in the rostral ventrolateral medulla modulates enhanced cardiac sympathetic afferent reflex and sympathetic activation in renovascular hypertensive rats. 61
23424239 2013
596
When the chimney is blocked: malignant renovascular hypertension after endovascular repair of abdominal aortic aneurysm. 61
23531087 2013
597
Takayasu's arteritis presenting as renovascular hypertension. 61
23538372 2013
598
Primary angiosarcoma of the aorta, great vessels, and the heart. 61
23312835 2013
599
Ischemic nephropathy: more than a simple renal artery narrowing. 61
23485531 2013
600
Takayasu's arteritis and posterior reversible encephalopathy syndrome: a case-based review. 61
23292521 2013
601
The nonpeptide ANG-(1-7) mimic AVE 0991 attenuates cardiac remodeling and improves baroreflex sensitivity in renovascular hypertensive rats. 61
23333828 2013
602
Renovascular hypertension--is it fibromuscular dysplasia or Takayasu arteritis. 61
22453736 2013
603
[Effect of puerarin combined with felodipine on mRNA and protein expression of apelin and APJ in renovascular hypertensive rat]. 61
23668014 2013
604
Chronic renal artery dissection with aneurysm formation treated by stent implantation with coil embolization with detailed intravascular ultrasound evaluation. 61
22511619 2013
605
Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy. 61
23073243 2013
606
Renal biopsy research in the former soviet union: prevention of a negligent custom. 61
24967233 2013
607
Treatment for renovascular hypertension due to fibromuscular dysplasia of renal arteries with renal autotransplantation. 61
23511770 2013
608
An Unusual Case of Fibromuscular Dysplasia with Bilateral Renal Macroaneurysms: Three-year Outcome After Endovascular Treatment. 61
24044026 2013
609
Nicousamide normalizes renovascular hypertension in two-kidney one-clip hypertensive rats. 61
24648900 2013
610
Hypertensive crises in the adolescent: evaluation of suspected renovascular hypertension. 61
23585409 2013
611
Reproductive dysfunction in female rats with renovascular hypertension. 61
23382333 2013
612
Cuminum cyminum, a dietary spice, attenuates hypertension via endothelial nitric oxide synthase and NO pathway in renovascular hypertensive rats. 61
23402543 2013
613
Renal autotransplantation in renovascular hypertension secondary to renal artery aneurysm. 61
23712240 2013
614
Phosphodiesterase 5 attenuates the vasodilatory response in renovascular hypertension. 61
24260450 2013
615
Arterial baroreceptor reflex counteracts long-term blood pressure increase in the rat model of renovascular hypertension. 61
23762254 2013
616
Renovascular hypertension as a rare complication of laparoscopic extraperitoneal paraaortic lymphadenectomy. 61
23312254 2013
617
Mesenchymal stem cells (MSC) prevented the progression of renovascular hypertension, improved renal function and architecture. 61
24223811 2013
618
Peroxisome proliferator-activated receptor δ agonist, HPP593, prevents renal necrosis under chronic ischemia. 61
23691217 2013
619
Percutaneous revascularization for ischemic nephropathy: the past, present, and future. 61
23151953 2013
620
Middle aortic syndrome as the cause of renovascular hypertension in a 3-year-old girl: difficulties in the differential diagnosis. 61
23511769 2013
621
Endovascular treatment of stenoses in a pediatric patient with incomplete aortic duplication, mesenteric ischemia, and renovascular hypertension. 61
23141677 2013
622
[Mid-aortic syndrome in 18 year-old woman with arterial hypertension and bilateral renal artery stenosis]. 61
23348537 2013
623
DNA damage and augmented oxidative stress in bone marrow mononuclear cells from Angiotensin-dependent hypertensive mice. 61
23476745 2013
624
[Association of renovascular hypertension and primary aldosteronism]. 61
23102642 2012
625
Update on imaging for suspected renovascular hypertension in children and adolescents. 61
22986909 2012
626
Euterpe oleracea Mart.-derived polyphenols prevent endothelial dysfunction and vascular structural changes in renovascular hypertensive rats: role of oxidative stress. 61
23052352 2012
627
A rare association of fibromuscular dysplasia, renal agenesis, renal arteriovenous fistulae, and vertebral anomalies: expanding the V in VACTERL association. 61
23023878 2012
628
Epidemiology and optimal management in patients with renal artery stenosis. 61
23023722 2012
629
Chronic renovascular hypertension is associated with elevated levels of neutrophil gelatinase-associated lipocalin. 61
22923545 2012
630
Evaluation of density and distribution of CART-immunoreactive structures in gastrointestinal tract of hypertensive rats. 61
22887004 2012
631
Renal artery revascularisation can restore kidney function with absent radiotracer uptake. 61
22744769 2012
632
α-lipoic acid reduces hypertension and increases baroreflex sensitivity in renovascular hypertensive rats. 61
23143148 2012
633
[Renovascular hypertension secondary to pheochromocytoma]. 61
22534167 2012
634
Endogenous renovascular hypertension combined with low shear stress induces plaque rupture in apolipoprotein E-deficient mice. 61
22904273 2012
635
Irbesartan and emodin on myocardial remodeling in Goldblatt hypertensive rats. 61
23064242 2012
636
Reduction of rat cardiac hypertrophy by osthol is related to regulation of cardiac oxidative stress and lipid metabolism. 61
22918576 2012
637
[Endovascular management of a ruptured pseudoaneurysm of a rectal artery]. 61
24490200 2012
638
Retroperitoneoscopic nephrectomy for non-functioning kidneys related to renal stone disease. 61